{"gene":"FOS","run_date":"2026-06-09T23:54:44","timeline":{"discoveries":[{"year":1992,"finding":"c-Fos is essential for osteoclast and bone development in vivo; c-fos knockout mice develop osteopetrosis with deficiencies in bone remodeling and altered haematopoiesis, defining c-Fos as a required transcription factor for specific cellular differentiation compartments.","method":"Gene targeting in embryonic stem cells; homozygous knockout mice phenotypic analysis","journal":"Nature","confidence":"High","confidence_rationale":"Tier 2 / Strong — clean genetic knockout with defined multi-organ phenotype, replicated across multiple labs subsequently","pmids":["1465144"],"is_preprint":false},{"year":1986,"finding":"c-fos mRNA is required for normal cell division in 3T3 cells; inducible antisense RNA complementary to c-fos mRNA decreased colony formation and inhibited cell proliferation.","method":"Antisense RNA gene transfer with inducible MMTV promoter; colony formation and proliferation assays","journal":"Proceedings of the National Academy of Sciences of the United States of America","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — antisense knockdown with two orthogonal readouts (colony formation, proliferation), single lab","pmids":["3523478"],"is_preprint":false},{"year":1987,"finding":"c-fos mRNA undergoes rapid post-transcriptional degradation with a half-life of ~9 minutes, dependent on a destabilizing element in its 3' untranslated region; stabilization requires continued protein synthesis (cycloheximide blocks degradation).","method":"mRNA half-life measurements with 3' deletion/substitution mutants; cycloheximide treatment; Northern blot","journal":"Nucleic acids research","confidence":"High","confidence_rationale":"Tier 1 / Moderate — in vitro and cell-based mRNA stability assays with mutagenesis of 3' UTR, single lab but multiple orthogonal approaches","pmids":["3103102"],"is_preprint":false},{"year":1989,"finding":"c-Fos protein trans-represses its own promoter (c-fos autoregulation) through the serum response element (SRE); this trans-repression requires the leucine zipper (protein complex formation) but not AP-1/ATF sites, and is distinct from trans-activation.","method":"Transient transfection with Fos leucine zipper and DNA-binding mutants; reporter gene assays with c-fos promoter deletions","journal":"Cell","confidence":"High","confidence_rationale":"Tier 1 / Moderate — mutagenesis of functional domains combined with promoter reporter assays, mechanistic dissection of repression versus activation, single lab with multiple orthogonal constructs","pmids":["2513130"],"is_preprint":false},{"year":1988,"finding":"Mutations at the C-terminus of Fos protein (of the type found in virally-transduced transforming Fos variants) prevent rapid down-regulation of c-fos transcription following serum stimulation and act dominantly in trans to prevent down-regulation of a co-transfected c-fos gene.","method":"Transient co-transfection with C-terminal Fos mutants; run-on transcription assays","journal":"The EMBO journal","confidence":"Medium","confidence_rationale":"Tier 1 / Moderate — mutagenesis with functional transcriptional readout, dominant trans effect demonstrated, single lab","pmids":["3149583"],"is_preprint":false},{"year":1991,"finding":"c-Fos forms stable heterodimers with c-Jun, JunB, and JunD through their leucine zipper domains; heterodimers bind AP-1 sites and regulate transcription. c-Fos stimulates transcriptional activity of c-Jun heterodimers, whereas Fra-2 (and Fra-1) suppress c-Jun transactivation, with differences mapping to C-terminal regions.","method":"In vitro dimerization assays; gel shift/EMSA; transient transfection reporter assays; chimeric protein analysis","journal":"Nucleic acids research","confidence":"High","confidence_rationale":"Tier 1 / Moderate — in vitro reconstitution of heterodimers, DNA binding assays, and functional transactivation assays with chimeric proteins, single lab but multiple orthogonal methods","pmids":["1945831"],"is_preprint":false},{"year":1992,"finding":"c-Fos stability is regulated by dimerization with phosphorylated c-Jun: phosphorylated c-Jun targets c-Fos for degradation in a signal-dependent manner, whereas phorbol ester-induced (dephosphorylated) c-Jun stabilizes c-Fos. v-Fos is not susceptible to c-Jun-targeted degradation.","method":"Transient expression assays; in vitro degradation experiments with phosphorylated vs. unphosphorylated c-Jun","journal":"Science","confidence":"High","confidence_rationale":"Tier 1 / Moderate — in vitro degradation reconstitution plus cell-based transient expression, mechanistic dissection with phosphorylation state manipulation, single lab","pmids":["1470918"],"is_preprint":false},{"year":1996,"finding":"c-Fos is phosphorylated by MAP kinase and RSK at serines 362 and 374 (rat) in vivo during early G1; phosphorylation-mimicking mutations (S→D) increase c-Fos stability and AP-1 transactivation activity, whereas alanine substitutions reduce stability, indicating phosphorylation supports proliferative responses.","method":"In vitro kinase assays with MAP kinase and RSK; site-directed mutagenesis (Asp/Ala substitutions); AP-1 reporter assays; protein half-life measurements","journal":"Oncogene","confidence":"High","confidence_rationale":"Tier 1 / Strong — in vitro kinase assay plus mutagenesis plus functional (transactivation, transformation, stability) readouts, multiple orthogonal methods in single study","pmids":["8622865"],"is_preprint":false},{"year":1996,"finding":"c-Fos protein can induce apoptosis in preneoplastic cells in a manner that does not require new protein synthesis, does not involve its transcriptional activation activity (v-Fos which is transcriptionally active but lacks repression activity fails to induce apoptosis), and is blocked by Bcl-2 overexpression and requires p53.","method":"Chimeric c-FosER fusion protein activation; cycloheximide treatment; Bcl-2 co-expression; p53-null cell lines and HPV E6-mediated p53 knockdown; apoptosis assays","journal":"Molecular and cellular biology","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — multiple cell lines and genetic manipulations in single lab, but complex interpretation; v-Fos comparison provides mechanistic separation of activities","pmids":["8524298"],"is_preprint":false},{"year":2001,"finding":"c-Fos associates with the endoplasmic reticulum and activates phospholipid metabolism by an AP-1-independent cytoplasmic activity; two waves of c-Fos expression stimulate sequential synthesis of signaling polyphosphoinositides then membrane-biogenesis phospholipids; a peptide blocking AP-1 nuclear import does not affect this lipid activation.","method":"32P-orthophosphate incorporation into lipid fractions; immunocytochemistry showing ER localization; AP-1 nuclear import blockade peptide; timing of c-Fos expression waves","journal":"FASEB journal","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — direct ER localization by immunocytochemistry plus lipid labeling assays with AP-1 independence demonstrated, single lab","pmids":["11259365"],"is_preprint":false},{"year":2006,"finding":"c-Fos/ER association and cytoplasmic phospholipid synthesis activation are regulated by the phosphorylation state of c-Fos N-terminal tyrosine residues 10 and 30: tyrosine-phosphorylated c-Fos is not ER-membrane bound, while dephosphorylated c-Fos associates with the ER and promotes phospholipid synthesis.","method":"Site-directed mutagenesis of tyrosine residues; subcellular fractionation; 32P-lipid labeling; phosphotyrosine immunoblotting; cell proliferation assays","journal":"Oncogene","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — mutagenesis of specific tyrosine residues with functional lipid synthesis readout and subcellular localization, single lab","pmids":["17160021"],"is_preprint":false},{"year":2008,"finding":"c-Fos activates glucosylceramide synthase (GlcCerS) and glycolipid synthesis in PC12 cells; c-Fos physically interacts with GlcCerS as demonstrated by co-immunoprecipitation, and activates its enzymatic activity without affecting downstream glycolipid synthesis enzymes.","method":"Metabolic labeling of glycolipids; co-immunoprecipitation of c-Fos with V5-tagged GlcCerS; enzymatic activity assays for GlcCerS and downstream enzymes","journal":"The Journal of biological chemistry","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — Co-IP plus enzyme activity assays, single lab, two orthogonal methods","pmids":["18784083"],"is_preprint":false},{"year":2011,"finding":"c-Fos physically interacts with and activates CDP-diacylglycerol synthase and phosphatidylinositol 4-kinase IIα (but not PtdIns synthase or PtdIns 4-kinase IIβ) via its N-terminal domain, stimulating polyphosphoinositide synthesis; interaction confirmed by co-immunoprecipitation and FRET.","method":"In vitro enzyme activity assays; co-immunoprecipitation; FRET (fluorescence resonance energy transfer); N-terminal domain truncation constructs","journal":"Molecular biology of the cell","confidence":"High","confidence_rationale":"Tier 1 / Moderate — in vitro enzyme assays, co-IP, and FRET showing physical interaction, domain mapping, multiple orthogonal methods in single study","pmids":["21998197"],"is_preprint":false},{"year":1991,"finding":"c-Fos and c-Jun are substrates for calpain (calcium-dependent neutral protease) in vitro; calpain efficiently digests both proteins, and c-Jun calpain activity can be modified in vivo by manipulating calpastatin (endogenous calpain inhibitor) levels.","method":"In vitro calpain digestion assay; calpastatin overexpression/manipulation in cultured cells","journal":"FEBS letters","confidence":"Medium","confidence_rationale":"Tier 1 / Moderate — in vitro biochemical assay plus cell-based validation, single lab","pmids":["1908791"],"is_preprint":false},{"year":1996,"finding":"Lysosomes selectively take up and degrade c-Fos in a cell-free assay; lysosomal uptake of c-Fos is regulated by dimerization with differentially phosphorylated c-Jun, and c-Fos is immunologically detected in leupeptin-treated rat liver lysosomes in vivo, while v-Fos escapes this regulation.","method":"Cell-free lysosome uptake/degradation assay; immunological detection of c-Fos in purified lysosomes from leupeptin-treated rats","journal":"FEBS letters","confidence":"Medium","confidence_rationale":"Tier 1 / Moderate — cell-free reconstitution plus in vivo lysosomal detection, single lab, two orthogonal approaches","pmids":["8706827"],"is_preprint":false},{"year":2004,"finding":"JNK-mediated phosphorylation of newly synthesized c-Fos at serine residues protects c-Fos from proteasomal degradation in cardiomyocytes; dephosphorylation by PP2A (but not PP2B/calcineurin) triggers ubiquitin-dependent proteasomal degradation of c-Fos.","method":"Pharmacological JNK inhibitor; proteasome inhibitors (MG132, PI-1); PP2A and PP2B phosphatase treatment of immunoprecipitated c-Fos; phosphoserine/threonine immunoblotting; ubiquitin immunoprecipitation","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 1 / Moderate — multiple pharmacological and biochemical approaches with mechanistic dissection of kinase/phosphatase regulation of proteasomal degradation in single study","pmids":["15136564"],"is_preprint":false},{"year":1993,"finding":"MyoD binds a site overlapping the serum response element (SRE) in the c-fos promoter and acts as a negative transcriptional regulator of c-fos, blocking serum responsiveness; this identifies a mechanism by which MyoD can inhibit growth-responsive gene expression during muscle differentiation.","method":"Promoter deletion/mutation analysis; gel shift assays identifying MyoD binding site; transient transfection reporter assays in muscle cells","journal":"Nature","confidence":"Medium","confidence_rationale":"Tier 1 / Moderate — promoter mutagenesis, gel-shift identification of binding site, and functional reporter assays, single lab","pmids":["8386804"],"is_preprint":false},{"year":2002,"finding":"c-Fos regulates neuronal excitability and survival by controlling expression of the kainic acid receptor GluR6 and BDNF; hippocampus-specific c-fos knockout mice show increased kainic acid-induced seizures, neuronal excitability, and neuronal death.","method":"Conditional hippocampus-specific c-fos knockout mice; kainic acid-induced seizure model; in vivo and in vitro gene expression analysis of GluR6 and BDNF","journal":"Nature genetics","confidence":"High","confidence_rationale":"Tier 2 / Strong — conditional KO with defined neuronal phenotype plus identification of downstream target genes (GluR6, BDNF) in vivo and in vitro, multiple orthogonal readouts","pmids":["11925568"],"is_preprint":false},{"year":2006,"finding":"c-Fos produced in D1 receptor-expressing neurons regulates acquisition and extinction of cocaine-induced persistent changes; c-Fos-deficient neurons show altered expression of transcription factors, neurotransmitter receptors, and intracellular signaling molecules, and blunted dendritic remodeling of medium spiny neurons after repeated cocaine.","method":"Neuron-specific (D1 receptor-expressing) c-fos conditional knockout mice; cocaine sensitization and conditioned place preference behavioral tests; Western blot and immunohistochemistry for downstream targets; dendritic morphology analysis","journal":"The Journal of neuroscience","confidence":"High","confidence_rationale":"Tier 2 / Strong — conditional cell-type-specific KO with multiple molecular and behavioral readouts, single lab but multiple orthogonal methods","pmids":["17182779"],"is_preprint":false},{"year":2003,"finding":"STAT3 (but not STAT1) accumulates on the chromosomal c-fos promoter and independently boosts transcription; STAT3 cooperates with resident nuclear proteins (ELK1) activated by MAPK pathways to produce additive transcriptional increases, acting on the native chromosomal gene.","method":"Chromatin immunoprecipitation (ChIP) on endogenous c-fos promoter; transient transfection with STAT3/STAT1; luciferase reporter assays","journal":"The Journal of biological chemistry","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — ChIP on endogenous chromosomal gene plus reporter assays, single lab, two orthogonal methods","pmids":["12600988"],"is_preprint":false},{"year":2003,"finding":"The MEK5-ERK5 pathway phosphorylates and stabilizes c-Fos at sites distinct from those phosphorylated by ERK1/2, and the C-terminal half of ERK5 is required for maximal activation of c-Fos transactivation activity.","method":"In vitro kinase assays; dominant-negative and constitutively active MEK5/ERK5 constructs; c-Fos stability/phosphorylation assays; AP-1 reporter assays","journal":"Genes to cells","confidence":"Medium","confidence_rationale":"Tier 1 / Moderate — in vitro kinase assay plus cell-based phosphorylation and transactivation assays, single lab","pmids":["12622723"],"is_preprint":false},{"year":2010,"finding":"c-Fos intranuclear mobility and distribution are differentially regulated by its Jun dimerization partners: heterodimerization with c-Jun causes dramatic reduction in c-Fos nuclear mobility and redistribution to the nuclear matrix independently of AP-1/CRE DNA binding, while dimerization with JunB does not affect c-Fos mobility but alters its intranuclear distribution differently.","method":"FRAP (fluorescence recovery after photobleaching); co-immunoprecipitation; subcellular fractionation; fluorescent protein fusions; genetic mutants lacking DNA-binding capacity","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 2 / Strong — FRAP live-cell imaging, co-IP, fractionation, and domain mutants all converging on same mechanistic conclusion, single lab but multiple orthogonal methods","pmids":["20053986"],"is_preprint":false},{"year":1998,"finding":"c-Fos dimerization with c-Jun (through the leucine zipper) represses c-Jun-mediated enhancement of androgen receptor transactivation; the bZIP leucine zipper (dimerization) domain of c-Fos is required and sufficient for this inhibition, while DNA binding is dispensable.","method":"Transient transfection reporter assays with c-Fos truncation mutants; hKLK2 promoter-luciferase constructs","journal":"Endocrine","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — systematic truncation mutagenesis with functional transcriptional readout, single lab","pmids":["9867253"],"is_preprint":false},{"year":2001,"finding":"c-Fos and c-Jun co-activate connexin43 (Cx43) promoter through an AP-1 site; mutation of the AP-1 site reduces this responsiveness, identifying Cx43 as a direct transcriptional target of c-Fos/c-Jun AP-1 complexes in myometrial cells.","method":"Transient co-transfection with c-Fos and c-Jun expression vectors; Cx43 promoter-luciferase reporter; AP-1 site mutation","journal":"Cell communication & adhesion","confidence":"Medium","confidence_rationale":"Tier 2 / Weak — single promoter reporter assay with AP-1 site mutagenesis, single lab, single method","pmids":["12064606"],"is_preprint":false},{"year":2013,"finding":"TLR7 negatively regulates dendrite outgrowth through a Myd88-c-Fos-IL-6 signaling pathway; TLR7 activation induces IL-6 through Myd88, and c-Fos is required for this pathway as shown by genetic knockouts of Myd88 and IL-6.","method":"In vitro neuronal cultures; in utero electroporation; Myd88-/-, IL-6-/-, TNFα-/- neurons; TLR7 agonist treatments; dendrite morphology quantification","journal":"The Journal of neuroscience","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — genetic epistasis with multiple KO neurons and pharmacological TLR7 agonists, single lab, pathway position defined","pmids":["23843519"],"is_preprint":false},{"year":2021,"finding":"MEF2C directly binds FOS regulatory regions to induce c-FOS expression, which then activates NFATc1 and drives osteoclastogenesis; MEF2C-mediated c-FOS induction is required for RANKL-induced osteoclast differentiation.","method":"ChIP assay showing MEF2C binding to FOS regulatory regions; MEF2C ectopic expression and knockdown; conditional Mef2c knockout mice; osteoclastogenesis assays; transcriptomic analysis","journal":"Bone research","confidence":"High","confidence_rationale":"Tier 2 / Strong — ChIP identifying direct binding site, conditional KO mice, ectopic expression/knockdown, and transcriptomic data converge on same pathway conclusion","pmids":["33424022"],"is_preprint":false},{"year":2006,"finding":"A single c-Jun/c-Fos AP-1 dimer is sufficient for osteoclast differentiation from c-Fos-deficient hematopoietic precursors; c-Fos heterodimerized with any Jun protein (including JNK-phosphorylation-site mutant c-Jun) rescues osteoclastogenesis, but Fra1 with any Jun protein cannot rescue, suggesting c-Fos has broader AP-1 site transactivation capability required for osteoclast differentiation.","method":"Synthetic single-chain AP-1 dimers (tethered via linker); rescue of osteoclastogenesis from c-Fos-deficient precursors; transient transfection AP-1 reporter assays","journal":"Bone","confidence":"High","confidence_rationale":"Tier 2 / Strong — reconstitution of function with defined synthetic dimers, systematic comparison of Fos/Fra1 with multiple Jun partners, genetic rescue in c-Fos-null background","pmids":["17189721"],"is_preprint":false},{"year":2023,"finding":"c-Fos modulates cellular bioenergetics in chondrocytes by balancing pyruvate flux between anaerobic glycolysis and the TCA cycle; cartilage-specific c-Fos knockout mice show decreased pyruvate dehydrogenase (Pdh) activity, elevated lactate dehydrogenase (Ldh) activity, and elevated HIF-1α/Pdk1/Ldha expression, with exacerbated OA. DCA (Pdk inhibitor) treatment rescues these metabolic and structural defects.","method":"Cartilage-specific conditional c-fos knockout (c-FosΔCh); DMM OA model; RNA-seq; in situ metabolic enzyme activity assays for Pdh and Ldh; DCA pharmacological rescue","journal":"Annals of the rheumatic diseases","confidence":"High","confidence_rationale":"Tier 2 / Strong — conditional KO, in situ enzyme assays, RNA-seq, and pharmacological rescue all in same study establishing c-Fos as metabolic regulator in chondrocytes","pmids":["37344157"],"is_preprint":false},{"year":2023,"finding":"PRMT1 directly interacts with c-Fos and methylates it at arginine 287 (mono- and dimethylation), protecting c-Fos from autophagic degradation and enhancing AP-1 transcriptional activity; PRMT1 knockdown decreases c-Fos protein levels, and R287 methylation promotes c-Fos protein stabilization.","method":"Co-immunoprecipitation; mass spectrometry identification of methylation sites; PRMT1 knockdown; autophagy inhibition experiments; AP-1 reporter assays","journal":"International journal of biological sciences","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — Co-IP, MS identification of modification site, functional rescue experiments; single lab with multiple methods but full mutagenesis validation not explicitly described in abstract","pmids":["37564212"],"is_preprint":false},{"year":2015,"finding":"During MAPK induction, transcription factor concentration modulates the burst frequency of c-Fos transcription; the polymerase initiation frequency is linked to transactivation domain strength, and burst duration is linked to TF lifetime on the promoter, as shown using synthetic TALE-based TFs.","method":"Single-molecule FISH (smFISH) with computational modeling; synthetic TALE transcription factors targeting c-Fos promoter; quantification at individual endogenous alleles","journal":"Cell reports","confidence":"High","confidence_rationale":"Tier 1 / Strong — quantitative single-molecule imaging at endogenous locus combined with synthetic TF engineering and computational modeling, multiple orthogonal approaches in single study","pmids":["24981864"],"is_preprint":false},{"year":2015,"finding":"Multiple enhancers surrounding the c-fos gene are required for robust c-fos response to various stimuli; membrane depolarization, BDNF, and forskolin activate distinct subsets of enhancers to induce c-fos transcription in neurons, with different key transcription factors required depending on the type of stimulation.","method":"Enhancer deletion/mutation analysis; luciferase reporter assays; ChIP; neuronal stimulation with defined stimuli; in vivo brain activation","journal":"Nature neuroscience","confidence":"High","confidence_rationale":"Tier 2 / Strong — systematic enhancer functional mapping with multiple stimuli, ChIP, and in vivo validation, demonstrating stimulus-specific combinatorial enhancer activation","pmids":["26595656"],"is_preprint":false},{"year":2021,"finding":"c-FOS drives basal to squamous cell carcinoma transition (BST) by regulating the accessibility of distinct AP-1 regulatory elements; c-FOS-mediated BST is reversible, and EGFR pathway blockade after c-FOS induction reverts BST in vitro and prevents BST features in mouse models and human tumors.","method":"Inducible c-FOS expression systems; ATAC-seq/chromatin accessibility assays; EGFR inhibitor treatment; mouse models; patient single-cell and bulk transcriptomics","journal":"Cell reports","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — inducible expression system with chromatin accessibility readout and in vivo rescue, single lab","pmids":["34610301"],"is_preprint":false},{"year":1998,"finding":"RNA polymerases are constitutively engaged at the c-fos promoter-proximal region in the absence of activation signals but terminate close to the promoter; activation of c-fos expression results primarily from assembly of elongation-competent RNA polymerases that can transcribe the complete gene, establishing transcription elongation as a key regulatory step.","method":"Nuclear run-on transcription analysis at nucleotide resolution in intact cells; promoter occupancy and chromatin conformation analysis","journal":"Journal of molecular biology","confidence":"Medium","confidence_rationale":"Tier 1 / Moderate — high-resolution nuclear run-on mapping in intact cells, single lab, mechanistic dissection of elongation vs. initiation regulation","pmids":["9671550"],"is_preprint":false}],"current_model":"c-Fos is a bZIP transcription factor that heterodimerizes with Jun family proteins via a leucine zipper to form AP-1 complexes that bind promoter AP-1 sites and regulate gene transcription; it autoregulates its own promoter through the SRE, undergoes rapid mRNA decay (~9 min half-life) via a 3'-UTR destabilizing element, and is post-translationally regulated by phosphorylation (by MAP kinase/RSK stabilizing, JNK-mediated serine phosphorylation protecting from proteasomal degradation, and tyrosine dephosphorylation enabling ER association) and arginine methylation by PRMT1 (protecting from autophagic degradation); in addition to nuclear transcription factor activity, c-Fos localizes to the ER where it activates phospholipid and glycolipid synthesis enzymes (CDP-diacylglycerol synthase, PtdIns 4-kinase IIα, glucosylceramide synthase) via direct physical interaction; c-Fos is essential in vivo for osteoclast differentiation (where it acts upstream of NFATc1 and is induced by MEF2C), neuronal excitability/survival (regulating GluR6 and BDNF expression), chondrocyte metabolic homeostasis (balancing pyruvate flux between glycolysis and TCA cycle), and normal brain development."},"narrative":{"mechanistic_narrative":"c-Fos is an immediate-early gene product that functions as a bZIP transcription factor, dimerizing with c-Jun, JunB, and JunD through its leucine zipper to form AP-1 complexes that bind AP-1 sites and regulate transcription [PMID:1945831]; c-Jun heterodimers also remodel c-Fos nuclear mobility and redistribute it to the nuclear matrix independently of DNA binding [PMID:20053986]. Its own expression is tightly controlled at multiple levels: transcription is governed by stimulus-specific enhancer subsets and SRE/STAT3/ELK1 inputs, with regulation occurring substantially at the elongation step where promoter-proximal polymerases must be converted to elongation-competent forms, and transactivation strength setting transcriptional burst kinetics [PMID:12600988, PMID:24981864, PMID:26595656, PMID:9671550]; c-Fos additionally trans-represses its own promoter through the SRE via its leucine zipper, a function distinct from AP-1 transactivation [PMID:2513130]. The mRNA is intrinsically unstable (~9 min half-life) through a 3'-UTR destabilizing element [PMID:3103102]. c-Fos protein stability is set by a network of post-translational signals: MAPK/RSK and MEK5-ERK5 phosphorylation stabilize it and boost AP-1 activity, JNK serine phosphorylation protects it from PP2A-dependent proteasomal degradation, PRMT1-mediated arginine-287 methylation protects it from autophagic degradation, and dimerization with phosphorylated c-Jun targets it for degradation [PMID:8622865, PMID:12622723, PMID:15136564, PMID:37564212, PMID:1470918]. Beyond nuclear transcription, dephosphorylated (tyrosine-10/30) c-Fos associates with the endoplasmic reticulum, where it directly binds and activates lipid-synthesis enzymes — CDP-diacylglycerol synthase, PtdIns 4-kinase IIα, and glucosylceramide synthase — to drive phospholipid and glycolipid synthesis in an AP-1-independent manner [PMID:11259365, PMID:17160021, PMID:18784083, PMID:21998197]. In vivo, c-Fos is essential for osteoclast differentiation, acting downstream of MEF2C and upstream of NFATc1 [PMID:1465144, PMID:33424022, PMID:17189721], for neuronal excitability and survival via control of GluR6 and BDNF and for cocaine-induced neuronal plasticity [PMID:11925568, PMID:17182779], and for chondrocyte bioenergetic homeostasis by balancing pyruvate flux between glycolysis and the TCA cycle [PMID:37344157].","teleology":[{"year":1986,"claim":"Established that c-fos is functionally required for cell proliferation rather than being a passive marker of mitogenic stimulation.","evidence":"Inducible antisense c-fos RNA in 3T3 cells with colony-formation and proliferation readouts","pmids":["3523478"],"confidence":"Medium","gaps":["Antisense knockdown does not define which target genes mediate the proliferative effect","Single cell type"]},{"year":1987,"claim":"Defined the basis of c-fos transience by localizing an mRNA destabilizing element to the 3' UTR, explaining its immediate-early kinetics.","evidence":"mRNA half-life measurements with 3' UTR deletion/substitution mutants and cycloheximide treatment","pmids":["3103102"],"confidence":"High","gaps":["Trans-acting decay factors not identified","Link between protein synthesis requirement and decay machinery unresolved"]},{"year":1988,"claim":"Identified the Fos C-terminus as the determinant of transcriptional autodownregulation, distinguishing oncogenic from normal Fos.","evidence":"Co-transfection of C-terminal Fos mutants with run-on transcription assays","pmids":["3149583"],"confidence":"Medium","gaps":["Molecular mechanism of the C-terminal effect not defined","Single transient system"]},{"year":1989,"claim":"Separated c-Fos's repression of its own promoter from its activation function, showing autorepression requires dimerization but not DNA binding.","evidence":"Leucine zipper and DNA-binding mutants with c-fos promoter reporter assays","pmids":["2513130"],"confidence":"High","gaps":["Identity of the partner protein mediating SRE-based repression unresolved","Endogenous chromosomal relevance not tested here"]},{"year":1991,"claim":"Defined c-Fos and c-Jun as calpain substrates, introducing proteolysis as a route to limit AP-1 factor lifetime.","evidence":"In vitro calpain digestion plus calpastatin manipulation in cells","pmids":["1908791"],"confidence":"Medium","gaps":["Physiological significance of calpain cleavage of c-Fos in vivo not established","Cleavage sites not mapped"]},{"year":1991,"claim":"Established the AP-1 dimer logic by defining c-Fos as a Jun heterodimerization partner that activates, while Fra proteins suppress, Jun transactivation.","evidence":"In vitro dimerization, EMSA, and reporter assays with chimeric proteins","pmids":["1945831"],"confidence":"High","gaps":["Genome-wide target spectrum not addressed","C-terminal regions mapped only functionally"]},{"year":1992,"claim":"Demonstrated in vivo that c-Fos is indispensable for osteoclast-mediated bone remodeling, anchoring its differentiation role in a defined lineage.","evidence":"Homozygous c-fos knockout mice with osteopetrosis phenotype","pmids":["1465144"],"confidence":"High","gaps":["Downstream transcriptional targets in osteoclasts not identified at the time","Mechanism of lineage specificity unresolved"]},{"year":1992,"claim":"Linked c-Fos turnover to its dimerization partner's phosphorylation state, coupling signaling to AP-1 factor degradation.","evidence":"In vitro degradation and transient expression with phosphorylated vs. dephosphorylated c-Jun","pmids":["1470918"],"confidence":"High","gaps":["Degradation pathway (proteasomal vs lysosomal) not yet assigned","Phospho-sites on Jun driving the effect not mapped"]},{"year":1993,"claim":"Showed MyoD represses c-fos via an SRE-overlapping site, mechanistically connecting muscle differentiation to shut-off of growth-responsive genes.","evidence":"Promoter mutagenesis, gel shift, and reporter assays in muscle cells","pmids":["8386804"],"confidence":"Medium","gaps":["Endogenous chromosomal occupancy not shown","Generality beyond muscle cells untested"]},{"year":1996,"claim":"Mapped MAPK/RSK phosphorylation of c-Fos serines and tied it to increased stability and AP-1 activity during G1, defining a proliferative regulatory switch.","evidence":"In vitro kinase assays, Asp/Ala mutagenesis, half-life and AP-1 reporter assays","pmids":["8622865"],"confidence":"High","gaps":["Degradation machinery acted upon by phosphorylation not defined here","In vivo relevance of specific sites not tested"]},{"year":1996,"claim":"Revealed a transcription-independent pro-apoptotic activity of c-Fos requiring p53 and blockable by Bcl-2, separating it from AP-1 transactivation.","evidence":"c-FosER chimera activation in p53-null and Bcl-2-expressing cells with cycloheximide","pmids":["8524298"],"confidence":"Medium","gaps":["Molecular effector of the apoptotic activity not identified","Complex interpretation across multiple manipulations"]},{"year":1996,"claim":"Identified lysosomal selective degradation of c-Fos regulated by Jun dimerization, broadening the routes controlling c-Fos lifetime.","evidence":"Cell-free lysosome uptake assay and in vivo detection in leupeptin-treated rat liver lysosomes","pmids":["8706827"],"confidence":"Medium","gaps":["Targeting signal directing c-Fos to lysosomes not defined","Relative contribution vs proteasomal/autophagic pathways unclear"]},{"year":1998,"claim":"Defined c-fos transcriptional control as primarily an elongation checkpoint, showing engaged polymerases terminate near the promoter until activation.","evidence":"Nucleotide-resolution nuclear run-on in intact cells","pmids":["9671550"],"confidence":"Medium","gaps":["Factors driving the elongation switch not identified","Single-gene resolution limited to one system"]},{"year":1998,"claim":"Showed c-Fos can inhibit nuclear receptor signaling by sequestering c-Jun through its leucine zipper, a DNA-binding-independent repression.","evidence":"c-Fos truncation mutants with androgen-responsive promoter reporters","pmids":["9867253"],"confidence":"Medium","gaps":["Endogenous AR target relevance not tested","Single reporter system"]},{"year":2001,"claim":"Discovered a cytoplasmic, AP-1-independent c-Fos function at the ER activating phospholipid synthesis, extending its role beyond transcription.","evidence":"32P-lipid labeling, ER immunocytochemistry, and AP-1 nuclear-import blockade peptide","pmids":["11259365"],"confidence":"Medium","gaps":["Direct enzyme targets not yet identified in this study","Mechanism of ER recruitment unresolved"]},{"year":2001,"claim":"Identified connexin43 as a direct AP-1 target of c-Fos/c-Jun, providing a concrete transcriptional output.","evidence":"Co-transfection with Cx43 promoter reporter and AP-1 site mutation","pmids":["12064606"],"confidence":"Medium","gaps":["Single reporter assay without endogenous chromatin validation","Cell-type generality untested"]},{"year":2002,"claim":"Established a neuronal in vivo role for c-Fos in controlling excitability and survival through GluR6 and BDNF target regulation.","evidence":"Hippocampus-specific conditional c-fos knockout in a kainic acid seizure model","pmids":["11925568"],"confidence":"High","gaps":["Direct vs indirect regulation of GluR6/BDNF not fully separated","AP-1 site occupancy at these targets not shown"]},{"year":2003,"claim":"Showed STAT3 and ELK1 cooperate on the endogenous c-fos promoter, integrating cytokine and MAPK inputs at the native chromosomal gene.","evidence":"ChIP on endogenous c-fos promoter plus reporter assays","pmids":["12600988"],"confidence":"Medium","gaps":["Mechanism of STAT3-ELK1 additive cooperation not resolved","Single lab"]},{"year":2003,"claim":"Identified a distinct MEK5-ERK5 phosphorylation input stabilizing c-Fos and boosting its transactivation, separate from ERK1/2 sites.","evidence":"In vitro kinase assays with dominant-negative/constitutive MEK5/ERK5 and AP-1 reporters","pmids":["12622723"],"confidence":"Medium","gaps":["Exact ERK5 phosphosites not mapped","In vivo significance untested"]},{"year":2004,"claim":"Resolved the degradation logic by showing JNK serine phosphorylation protects newly synthesized c-Fos from PP2A-triggered, ubiquitin-dependent proteasomal degradation.","evidence":"JNK/proteasome inhibitors, PP2A/PP2B treatment of immunoprecipitated c-Fos, ubiquitin IP in cardiomyocytes","pmids":["15136564"],"confidence":"High","gaps":["E3 ligase mediating c-Fos ubiquitination not identified","Phosphosites protected by JNK not precisely mapped"]},{"year":2006,"claim":"Linked c-Fos tyrosine phosphorylation state to ER association, showing dephosphorylation of Tyr10/30 enables the lipid-synthesis activity.","evidence":"Tyrosine mutagenesis, subcellular fractionation, and 32P-lipid labeling","pmids":["17160021"],"confidence":"Medium","gaps":["Kinase/phosphatase controlling Tyr10/30 not identified","Structural basis of ER membrane binding unknown"]},{"year":2006,"claim":"Demonstrated that a single c-Jun/c-Fos AP-1 dimer suffices for osteoclastogenesis and that c-Fos cannot be substituted by Fra1, defining functional specificity within AP-1.","evidence":"Synthetic single-chain AP-1 dimers rescuing osteoclastogenesis from c-Fos-null precursors","pmids":["17189721"],"confidence":"High","gaps":["Molecular basis of c-Fos vs Fra1 transactivation difference not defined","Specific osteoclast target genes not enumerated"]},{"year":2006,"claim":"Extended the neuronal role of c-Fos to behavioral plasticity, showing D1-neuron c-Fos is required for cocaine-induced dendritic remodeling and gene expression changes.","evidence":"D1-neuron conditional c-fos knockout with behavioral, molecular, and dendritic readouts","pmids":["17182779"],"confidence":"High","gaps":["Direct c-Fos target genes driving remodeling not pinned down","Circuit-level mechanism unresolved"]},{"year":2008,"claim":"Identified glucosylceramide synthase as a direct c-Fos-interacting enzyme activated to drive glycolipid synthesis, broadening the ER lipid-activation program.","evidence":"Glycolipid metabolic labeling, co-IP with tagged GlcCerS, and enzyme activity assays in PC12 cells","pmids":["18784083"],"confidence":"Medium","gaps":["Mechanism of enzymatic activation not defined","Single cell type"]},{"year":2010,"claim":"Revealed that Jun partner identity controls c-Fos nuclear dynamics and matrix localization independently of DNA binding, adding a spatial layer to AP-1 regulation.","evidence":"FRAP, co-IP, fractionation, and DNA-binding mutants","pmids":["20053986"],"confidence":"High","gaps":["Functional consequence of nuclear matrix redistribution for target gene output unclear","Matrix-anchoring partners not identified"]},{"year":2011,"claim":"Established direct physical and functional engagement of c-Fos with CDP-diacylglycerol synthase and PtdIns 4-kinase IIα via its N-terminus, mechanistically grounding the ER lipid-synthesis role.","evidence":"In vitro enzyme assays, co-IP, FRET, and N-terminal truncations","pmids":["21998197"],"confidence":"High","gaps":["Structural model of c-Fos-enzyme complexes lacking","How nuclear vs ER c-Fos pools are partitioned unresolved"]},{"year":2015,"claim":"Connected transcription factor concentration and transactivation strength to the burst kinetics of c-fos transcription at single endogenous alleles.","evidence":"smFISH with synthetic TALE transcription factors and computational modeling","pmids":["24981864"],"confidence":"High","gaps":["Endogenous TFs setting burst behavior not exhaustively defined","Link to chromatin state not addressed"]},{"year":2015,"claim":"Defined stimulus-specific combinatorial enhancer usage controlling c-fos induction in neurons, explaining context-dependent activation.","evidence":"Enhancer deletion/mutation, reporters, ChIP, and in vivo brain activation","pmids":["26595656"],"confidence":"High","gaps":["Full TF complement at each enhancer not enumerated","Mechanism of enhancer-promoter selectivity unresolved"]},{"year":2021,"claim":"Placed c-FOS upstream in osteoclastogenesis as the MEF2C-induced activator of NFATc1, completing a defined RANKL-responsive transcriptional cascade.","evidence":"ChIP of MEF2C at FOS, conditional Mef2c knockout mice, expression manipulation, and transcriptomics","pmids":["33424022"],"confidence":"High","gaps":["Direct c-FOS occupancy at Nfatc1 not detailed here","Co-factors at FOS regulatory regions not fully mapped"]},{"year":2021,"claim":"Showed c-FOS drives a reversible basal-to-squamous carcinoma transition by remodeling AP-1 element accessibility, linking it to malignant cell-state plasticity.","evidence":"Inducible c-FOS, ATAC-seq, EGFR inhibition, mouse models, and patient transcriptomics","pmids":["34610301"],"confidence":"Medium","gaps":["Specific AP-1 elements driving transition not enumerated","Single lab"]},{"year":2023,"claim":"Defined c-Fos as a metabolic regulator in chondrocytes balancing pyruvate flux, with loss exacerbating osteoarthritis and rescuable by Pdk inhibition.","evidence":"Cartilage-specific c-fos knockout, DMM OA model, in situ enzyme assays, RNA-seq, and DCA rescue","pmids":["37344157"],"confidence":"High","gaps":["Direct transcriptional targets controlling Pdh/Ldh/HIF-1α axis not pinpointed","Whether the effect is AP-1-dependent not resolved"]},{"year":2023,"claim":"Identified PRMT1-mediated arginine-287 methylation as a stabilizing modification protecting c-Fos from autophagic degradation and enhancing AP-1 activity.","evidence":"Co-IP, mass spectrometry of methylation sites, PRMT1 knockdown, autophagy inhibition, and AP-1 reporters","pmids":["37564212"],"confidence":"Medium","gaps":["Full R287 mutagenesis validation not described","Autophagy receptor recognizing unmethylated c-Fos unknown"]},{"year":null,"claim":"How nuclear AP-1 transcription-factor c-Fos and the cytoplasmic ER-bound lipid-activating c-Fos pools are partitioned, coordinated, and integrated within a single cell remains unresolved.","evidence":"","pmids":[],"confidence":"Medium","gaps":["No structural model linking the two activities","Signals dictating nuclear vs ER fate not fully defined","Stoichiometry between pools unknown"]}],"mechanism_profile":{"molecular_activity":[{"term_id":"GO:0140110","term_label":"transcription regulator activity","supporting_discovery_ids":[3,5,7,23,26,30]},{"term_id":"GO:0003677","term_label":"DNA binding","supporting_discovery_ids":[5,23]},{"term_id":"GO:0098772","term_label":"molecular function regulator activity","supporting_discovery_ids":[9,11,12]},{"term_id":"GO:0060090","term_label":"molecular adaptor activity","supporting_discovery_ids":[22,21]}],"localization":[{"term_id":"GO:0005634","term_label":"nucleus","supporting_discovery_ids":[3,5,21]},{"term_id":"GO:0005783","term_label":"endoplasmic reticulum","supporting_discovery_ids":[9,10,11,12]}],"pathway":[{"term_id":"R-HSA-74160","term_label":"Gene expression (Transcription)","supporting_discovery_ids":[3,5,29,30,32]},{"term_id":"R-HSA-1266738","term_label":"Developmental Biology","supporting_discovery_ids":[0,25,26,17]},{"term_id":"R-HSA-1430728","term_label":"Metabolism","supporting_discovery_ids":[9,11,12,27]},{"term_id":"R-HSA-162582","term_label":"Signal Transduction","supporting_discovery_ids":[7,15,20,24]}],"complexes":["AP-1"],"partners":["JUN","JUNB","JUND","PRMT1","CDS1","PI4K2A","UGCG","STAT3"],"other_free_text":[]}},"prefetch_data":{"uniprot":{"accession":"P01100","full_name":"Protein c-Fos","aliases":["Cellular oncogene fos","Fos proto-oncogene, AP-1 transcription factor subunit","G0/G1 switch regulatory protein 7","Proto-oncogene c-Fos","Transcription factor AP-1 subunit c-Fos"],"length_aa":380,"mass_kda":40.7,"function":"Nuclear phosphoprotein which forms a tight but non-covalently linked complex with the JUN/AP-1 transcription factor. In the heterodimer, FOS and JUN/AP-1 basic regions each seems to interact with symmetrical DNA half sites. On TGF-beta activation, forms a multimeric SMAD3/SMAD4/JUN/FOS complex at the AP1/SMAD-binding site to regulate TGF-beta-mediated signaling. Has a critical function in regulating the development of cells destined to form and maintain the skeleton. It is thought to have an important role in signal transduction, cell proliferation and differentiation. In growing cells, activates phospholipid synthesis, possibly by activating CDS1 and PI4K2A. This activity requires Tyr-dephosphorylation and association with the endoplasmic reticulum","subcellular_location":"Nucleus; Endoplasmic reticulum; Cytoplasm, cytosol","url":"https://www.uniprot.org/uniprotkb/P01100/entry"},"depmap":{"release":"DepMap","has_data":true,"is_common_essential":false,"resolved_as":"","url":"https://depmap.org/portal/gene/FOS","classification":"Not Classified","n_dependent_lines":7,"n_total_lines":1208,"dependency_fraction":0.005794701986754967},"opencell":{"profiled":false,"resolved_as":"","ensg_id":"","cell_line_id":"","localizations":[],"interactors":[],"url":"https://opencell.sf.czbiohub.org/search/FOS","total_profiled":1310},"omim":[{"mim_id":"621482","title":"NEURODEVELOPMENTAL DISORDER WITH SEIZURES, HYPOTONIA, AND VARIABLE SPASTICITY; NEDSHS","url":"https://www.omim.org/entry/621482"},{"mim_id":"621173","title":"G PROTEIN-COUPLED RECEPTOR 146; GPR146","url":"https://www.omim.org/entry/621173"},{"mim_id":"620789","title":"APLASIA CUTIS-ENAMEL DYSPLASIA SYNDROME; ACED","url":"https://www.omim.org/entry/620789"},{"mim_id":"619654","title":"CHROMOSOME 3 OPEN READING FRAME 33; C3ORF33","url":"https://www.omim.org/entry/619654"},{"mim_id":"619499","title":"ZINC FINGER PROTEIN 383; ZNF383","url":"https://www.omim.org/entry/619499"}],"hpa":{"profiled":true,"resolved_as":"","reliability":"Supported","locations":[{"location":"Nucleoplasm","reliability":"Supported"}],"tissue_specificity":"Low tissue specificity","tissue_distribution":"Detected in all","driving_tissues":[],"url":"https://www.proteinatlas.org/search/FOS"},"hgnc":{"alias_symbol":["c-fos","AP-1"],"prev_symbol":[]},"alphafold":{"accession":"P01100","domains":[],"viewer_url":"https://alphafold.ebi.ac.uk/entry/P01100","model_url":"https://alphafold.ebi.ac.uk/files/AF-P01100-F1-model_v6.cif","pae_url":"https://alphafold.ebi.ac.uk/files/AF-P01100-F1-predicted_aligned_error_v6.png","plddt_mean":57.22},"mouse_models":{"mgi_url":"https://www.informatics.jax.org/marker/summary?nomen=FOS","jax_strain_url":"https://www.jax.org/strain/search?query=FOS"},"sequence":{"accession":"P01100","fasta_url":"https://rest.uniprot.org/uniprotkb/P01100.fasta","uniprot_url":"https://www.uniprot.org/uniprotkb/P01100/entry","alphafold_viewer_url":"https://alphafold.ebi.ac.uk/entry/P01100"}},"corpus_meta":[{"pmid":"2507830","id":"PMC_2507830","title":"The use of c-fos as a metabolic marker in neuronal pathway tracing.","date":"1989","source":"Journal of neuroscience methods","url":"https://pubmed.ncbi.nlm.nih.gov/2507830","citation_count":1274,"is_preprint":false},{"pmid":"1465144","id":"PMC_1465144","title":"Bone and haematopoietic defects in mice lacking c-fos.","date":"1992","source":"Nature","url":"https://pubmed.ncbi.nlm.nih.gov/1465144","citation_count":786,"is_preprint":false},{"pmid":"8971979","id":"PMC_8971979","title":"Activation of c-fos in the brain.","date":"1996","source":"Progress in neurobiology","url":"https://pubmed.ncbi.nlm.nih.gov/8971979","citation_count":607,"is_preprint":false},{"pmid":"2512584","id":"PMC_2512584","title":"Expression of c-Fos immunoreactivity in transmitter-characterized neurons after stress.","date":"1989","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/2512584","citation_count":512,"is_preprint":false},{"pmid":"3523478","id":"PMC_3523478","title":"Inducible production of c-fos antisense RNA inhibits 3T3 cell proliferation.","date":"1986","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/3523478","citation_count":511,"is_preprint":false},{"pmid":"1908006","id":"PMC_1908006","title":"c-fos mRNA, Fos, and Fos-related antigen induction by hypertonic saline and stress.","date":"1991","source":"The Journal of neuroscience : the official journal of the Society for Neuroscience","url":"https://pubmed.ncbi.nlm.nih.gov/1908006","citation_count":491,"is_preprint":false},{"pmid":"6093261","id":"PMC_6093261","title":"Expression of the c-fos gene and of an fos-related gene is stimulated by platelet-derived growth factor.","date":"1984","source":"Science (New York, N.Y.)","url":"https://pubmed.ncbi.nlm.nih.gov/6093261","citation_count":460,"is_preprint":false},{"pmid":"9434195","id":"PMC_9434195","title":"Using c-fos as a neural marker of pain.","date":"1998","source":"Brain research bulletin","url":"https://pubmed.ncbi.nlm.nih.gov/9434195","citation_count":421,"is_preprint":false},{"pmid":"3887183","id":"PMC_3887183","title":"Induction of c-fos during myelomonocytic differentiation and macrophage proliferation.","date":"1985","source":"Nature","url":"https://pubmed.ncbi.nlm.nih.gov/3887183","citation_count":363,"is_preprint":false},{"pmid":"11925568","id":"PMC_11925568","title":"c-fos regulates neuronal excitability and survival.","date":"2002","source":"Nature genetics","url":"https://pubmed.ncbi.nlm.nih.gov/11925568","citation_count":286,"is_preprint":false},{"pmid":"1720578","id":"PMC_1720578","title":"How chicks make memories: the cellular cascade from c-fos to dendritic remodelling.","date":"1991","source":"Trends in neurosciences","url":"https://pubmed.ncbi.nlm.nih.gov/1720578","citation_count":247,"is_preprint":false},{"pmid":"3103102","id":"PMC_3103102","title":"Posttranscriptional regulation of c-fos mRNA expression.","date":"1987","source":"Nucleic acids research","url":"https://pubmed.ncbi.nlm.nih.gov/3103102","citation_count":229,"is_preprint":false},{"pmid":"8524298","id":"PMC_8524298","title":"Induction of apoptosis by c-Fos protein.","date":"1996","source":"Molecular and cellular biology","url":"https://pubmed.ncbi.nlm.nih.gov/8524298","citation_count":228,"is_preprint":false},{"pmid":"3141795","id":"PMC_3141795","title":"Estrogen regulation of c-fos messenger ribonucleic acid.","date":"1988","source":"Molecular endocrinology (Baltimore, Md.)","url":"https://pubmed.ncbi.nlm.nih.gov/3141795","citation_count":220,"is_preprint":false},{"pmid":"3085953","id":"PMC_3085953","title":"c-fos expression is neither sufficient nor obligatory for differentiation of monomyelocytes to macrophages.","date":"1986","source":"Cell","url":"https://pubmed.ncbi.nlm.nih.gov/3085953","citation_count":220,"is_preprint":false},{"pmid":"24981864","id":"PMC_24981864","title":"Transcription factors modulate c-Fos transcriptional bursts.","date":"2014","source":"Cell reports","url":"https://pubmed.ncbi.nlm.nih.gov/24981864","citation_count":219,"is_preprint":false},{"pmid":"26595656","id":"PMC_26595656","title":"Stimulus-specific combinatorial functionality of neuronal c-fos enhancers.","date":"2015","source":"Nature neuroscience","url":"https://pubmed.ncbi.nlm.nih.gov/26595656","citation_count":219,"is_preprint":false},{"pmid":"1945831","id":"PMC_1945831","title":"Difference in transcriptional regulatory function between c-Fos and Fra-2.","date":"1991","source":"Nucleic acids research","url":"https://pubmed.ncbi.nlm.nih.gov/1945831","citation_count":209,"is_preprint":false},{"pmid":"2513130","id":"PMC_2513130","title":"trans-repression of the mouse c-fos promoter: a novel mechanism of Fos-mediated trans-regulation.","date":"1989","source":"Cell","url":"https://pubmed.ncbi.nlm.nih.gov/2513130","citation_count":203,"is_preprint":false},{"pmid":"8386370","id":"PMC_8386370","title":"Persistent induction of c-fos and c-jun expression by asbestos.","date":"1993","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/8386370","citation_count":175,"is_preprint":false},{"pmid":"9483519","id":"PMC_9483519","title":"Forebrain expression of c-fos due to active maternal behaviour in lactating rats.","date":"1998","source":"Neuroscience","url":"https://pubmed.ncbi.nlm.nih.gov/9483519","citation_count":168,"is_preprint":false},{"pmid":"1908791","id":"PMC_1908791","title":"Degradation of transcription factors, c-Jun and c-Fos, by calpain.","date":"1991","source":"FEBS letters","url":"https://pubmed.ncbi.nlm.nih.gov/1908791","citation_count":157,"is_preprint":false},{"pmid":"8622865","id":"PMC_8622865","title":"Phosphorylation of c-Fos at the C-terminus enhances its transforming activity.","date":"1996","source":"Oncogene","url":"https://pubmed.ncbi.nlm.nih.gov/8622865","citation_count":146,"is_preprint":false},{"pmid":"25446457","id":"PMC_25446457","title":"Using c-fos to study neuronal ensembles in corticostriatal circuitry of addiction.","date":"2014","source":"Brain research","url":"https://pubmed.ncbi.nlm.nih.gov/25446457","citation_count":142,"is_preprint":false},{"pmid":"3144275","id":"PMC_3144275","title":"Morphine activation of c-fos expression in rat brain.","date":"1988","source":"Biochemical and biophysical research communications","url":"https://pubmed.ncbi.nlm.nih.gov/3144275","citation_count":142,"is_preprint":false},{"pmid":"2431900","id":"PMC_2431900","title":"c-myc and c-fos expression in differentiating mouse primary keratinocytes.","date":"1986","source":"The EMBO journal","url":"https://pubmed.ncbi.nlm.nih.gov/2431900","citation_count":134,"is_preprint":false},{"pmid":"17182779","id":"PMC_17182779","title":"c-Fos facilitates the acquisition and extinction of cocaine-induced persistent changes.","date":"2006","source":"The Journal of neuroscience : the official journal of the Society for Neuroscience","url":"https://pubmed.ncbi.nlm.nih.gov/17182779","citation_count":122,"is_preprint":false},{"pmid":"3561489","id":"PMC_3561489","title":"Modulation of c-fos gene transcription by negative and positive cellular factors.","date":"1987","source":"Nature","url":"https://pubmed.ncbi.nlm.nih.gov/3561489","citation_count":121,"is_preprint":false},{"pmid":"2572704","id":"PMC_2572704","title":"Induction of c-fos and TIS genes in cultured rat astrocytes by neurotransmitters.","date":"1989","source":"Journal of neuroscience research","url":"https://pubmed.ncbi.nlm.nih.gov/2572704","citation_count":120,"is_preprint":false},{"pmid":"2430291","id":"PMC_2430291","title":"Barium modulates c-fos expression and post-translational modification.","date":"1986","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/2430291","citation_count":119,"is_preprint":false},{"pmid":"39483772","id":"PMC_39483772","title":"Current Opinion on the Use of c-Fos in Neuroscience.","date":"2022","source":"NeuroSci","url":"https://pubmed.ncbi.nlm.nih.gov/39483772","citation_count":109,"is_preprint":false},{"pmid":"12933360","id":"PMC_12933360","title":"c-Fos expression in hypothalamic nuclei of food-entrained rats.","date":"2003","source":"American journal of physiology. Regulatory, integrative and comparative physiology","url":"https://pubmed.ncbi.nlm.nih.gov/12933360","citation_count":109,"is_preprint":false},{"pmid":"1470918","id":"PMC_1470918","title":"Targeted degradation of c-Fos, but not v-Fos, by a phosphorylation-dependent signal on c-Jun.","date":"1992","source":"Science (New York, N.Y.)","url":"https://pubmed.ncbi.nlm.nih.gov/1470918","citation_count":106,"is_preprint":false},{"pmid":"3133119","id":"PMC_3133119","title":"c-fos expression interferes with thymus development in transgenic mice.","date":"1988","source":"Cell","url":"https://pubmed.ncbi.nlm.nih.gov/3133119","citation_count":99,"is_preprint":false},{"pmid":"3149583","id":"PMC_3149583","title":"Fos C-terminal mutations block down-regulation of c-fos transcription following serum stimulation.","date":"1988","source":"The EMBO journal","url":"https://pubmed.ncbi.nlm.nih.gov/3149583","citation_count":99,"is_preprint":false},{"pmid":"8386804","id":"PMC_8386804","title":"Repression of c-fos promoter by MyoD on muscle cell differentiation.","date":"1993","source":"Nature","url":"https://pubmed.ncbi.nlm.nih.gov/8386804","citation_count":98,"is_preprint":false},{"pmid":"12622723","id":"PMC_12622723","title":"Regulation of c-Fos and Fra-1 by the MEK5-ERK5 pathway.","date":"2003","source":"Genes to cells : devoted to molecular & cellular mechanisms","url":"https://pubmed.ncbi.nlm.nih.gov/12622723","citation_count":90,"is_preprint":false},{"pmid":"8321410","id":"PMC_8321410","title":"c-fos expression in vasopressin and oxytocin neurons reveals functional heterogeneity within magnocellular neurons.","date":"1993","source":"Neuroendocrinology","url":"https://pubmed.ncbi.nlm.nih.gov/8321410","citation_count":88,"is_preprint":false},{"pmid":"15984408","id":"PMC_15984408","title":"Roles for NF-kappaB and c-Fos in osteoclasts.","date":"2005","source":"Journal of bone and mineral metabolism","url":"https://pubmed.ncbi.nlm.nih.gov/15984408","citation_count":84,"is_preprint":false},{"pmid":"12600988","id":"PMC_12600988","title":"Independent and cooperative activation of chromosomal c-fos promoter by STAT3.","date":"2003","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/12600988","citation_count":77,"is_preprint":false},{"pmid":"19395871","id":"PMC_19395871","title":"Pathogenesis of rheumatoid arthritis and c-Fos/AP-1.","date":"2009","source":"Cell cycle (Georgetown, Tex.)","url":"https://pubmed.ncbi.nlm.nih.gov/19395871","citation_count":75,"is_preprint":false},{"pmid":"3141205","id":"PMC_3141205","title":"Amygdala kindling and c-fos protein(s).","date":"1988","source":"Experimental neurology","url":"https://pubmed.ncbi.nlm.nih.gov/3141205","citation_count":74,"is_preprint":false},{"pmid":"10607147","id":"PMC_10607147","title":"Sleep deprivation and c-fos expression in the rat brain.","date":"1995","source":"Journal of sleep research","url":"https://pubmed.ncbi.nlm.nih.gov/10607147","citation_count":70,"is_preprint":false},{"pmid":"2114401","id":"PMC_2114401","title":"Insulin's regulation of c-fos gene transcription in hepatoma cells.","date":"1990","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/2114401","citation_count":67,"is_preprint":false},{"pmid":"3382942","id":"PMC_3382942","title":"Proto-oncogene c-fos induction in rat hippocampus.","date":"1988","source":"Brain research","url":"https://pubmed.ncbi.nlm.nih.gov/3382942","citation_count":67,"is_preprint":false},{"pmid":"10753978","id":"PMC_10753978","title":"Tactile experience induces c-fos expression in rat barrel cortex.","date":"2000","source":"Learning & memory (Cold Spring Harbor, N.Y.)","url":"https://pubmed.ncbi.nlm.nih.gov/10753978","citation_count":66,"is_preprint":false},{"pmid":"11259365","id":"PMC_11259365","title":"c-Fos associates with the endoplasmic reticulum and activates phospholipid metabolism.","date":"2001","source":"FASEB journal : official publication of the Federation of American Societies for Experimental Biology","url":"https://pubmed.ncbi.nlm.nih.gov/11259365","citation_count":64,"is_preprint":false},{"pmid":"3316710","id":"PMC_3316710","title":"The chicken c-fos gene: cloning and nucleotide sequence analysis.","date":"1987","source":"Journal of virology","url":"https://pubmed.ncbi.nlm.nih.gov/3316710","citation_count":64,"is_preprint":false},{"pmid":"7922576","id":"PMC_7922576","title":"Behavioral assessment of c-fos mutant mice.","date":"1994","source":"Brain research","url":"https://pubmed.ncbi.nlm.nih.gov/7922576","citation_count":63,"is_preprint":false},{"pmid":"23843519","id":"PMC_23843519","title":"TLR7 negatively regulates dendrite outgrowth through the Myd88-c-Fos-IL-6 pathway.","date":"2013","source":"The Journal of neuroscience : the official journal of the Society for Neuroscience","url":"https://pubmed.ncbi.nlm.nih.gov/23843519","citation_count":63,"is_preprint":false},{"pmid":"2258390","id":"PMC_2258390","title":"Microgravity decreases c-fos induction and serum response element activity.","date":"1990","source":"Journal of cell science","url":"https://pubmed.ncbi.nlm.nih.gov/2258390","citation_count":62,"is_preprint":false},{"pmid":"29673526","id":"PMC_29673526","title":"Genetic Reporters of Neuronal Activity: c-Fos and G-CaMP6.","date":"2018","source":"Methods in enzymology","url":"https://pubmed.ncbi.nlm.nih.gov/29673526","citation_count":61,"is_preprint":false},{"pmid":"9037533","id":"PMC_9037533","title":"Carbachol stimulates c-fos expression and proliferation in oligodendrocyte progenitors.","date":"1996","source":"Brain research. Molecular brain research","url":"https://pubmed.ncbi.nlm.nih.gov/9037533","citation_count":59,"is_preprint":false},{"pmid":"8511714","id":"PMC_8511714","title":"Expression of c-fos protein in the experimental epilepsy induced by pilocarpine.","date":"1993","source":"Synapse (New York, N.Y.)","url":"https://pubmed.ncbi.nlm.nih.gov/8511714","citation_count":56,"is_preprint":false},{"pmid":"10663966","id":"PMC_10663966","title":"Differential c-Fos and caspase expression following kainic acid excitotoxicity.","date":"2000","source":"Acta neuropathologica","url":"https://pubmed.ncbi.nlm.nih.gov/10663966","citation_count":53,"is_preprint":false},{"pmid":"8573144","id":"PMC_8573144","title":"C-Fos is not essential for apoptosis.","date":"1996","source":"Biochemical and biophysical research communications","url":"https://pubmed.ncbi.nlm.nih.gov/8573144","citation_count":51,"is_preprint":false},{"pmid":"10849652","id":"PMC_10849652","title":"Intracellular pathways linking hypoxia to activation of c-fos and AP-1.","date":"2000","source":"Advances in experimental medicine and biology","url":"https://pubmed.ncbi.nlm.nih.gov/10849652","citation_count":51,"is_preprint":false},{"pmid":"2512526","id":"PMC_2512526","title":"c-myc and c-fos gene regulation during mouse liver regeneration.","date":"1989","source":"Oncogene","url":"https://pubmed.ncbi.nlm.nih.gov/2512526","citation_count":50,"is_preprint":false},{"pmid":"33424022","id":"PMC_33424022","title":"MEF2C regulates osteoclastogenesis and pathologic bone resorption via c-FOS.","date":"2021","source":"Bone research","url":"https://pubmed.ncbi.nlm.nih.gov/33424022","citation_count":49,"is_preprint":false},{"pmid":"9097389","id":"PMC_9097389","title":"Regulation of c-Fos and NGF1-A by antidepressant treatments.","date":"1997","source":"Synapse (New York, N.Y.)","url":"https://pubmed.ncbi.nlm.nih.gov/9097389","citation_count":48,"is_preprint":false},{"pmid":"9228281","id":"PMC_9228281","title":"Complex mechanisms for c-fos and c-jun degradation.","date":"1997","source":"Molecular biology reports","url":"https://pubmed.ncbi.nlm.nih.gov/9228281","citation_count":45,"is_preprint":false},{"pmid":"17531086","id":"PMC_17531086","title":"Role of c-Fos/JunD in protecting stress-induced cell death.","date":"2007","source":"Cell proliferation","url":"https://pubmed.ncbi.nlm.nih.gov/17531086","citation_count":45,"is_preprint":false},{"pmid":"15136564","id":"PMC_15136564","title":"c-Fos phosphorylation induced by H2O2 prevents proteasomal degradation of c-Fos in cardiomyocytes.","date":"2004","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/15136564","citation_count":45,"is_preprint":false},{"pmid":"7755893","id":"PMC_7755893","title":"C-fos immunocytochemical evidence for acoustic pathway mapping in rats.","date":"1995","source":"Behavioural brain research","url":"https://pubmed.ncbi.nlm.nih.gov/7755893","citation_count":44,"is_preprint":false},{"pmid":"14737107","id":"PMC_14737107","title":"STAT3 and MITF cooperatively induce cellular transformation through upregulation of c-fos expression.","date":"2004","source":"Oncogene","url":"https://pubmed.ncbi.nlm.nih.gov/14737107","citation_count":44,"is_preprint":false},{"pmid":"36180824","id":"PMC_36180824","title":"A c-Fos activation map in nitroglycerin/levcromakalim-induced models of migraine.","date":"2022","source":"The journal of headache and pain","url":"https://pubmed.ncbi.nlm.nih.gov/36180824","citation_count":43,"is_preprint":false},{"pmid":"37344157","id":"PMC_37344157","title":"Metabolic rewiring controlled by c-Fos governs cartilage integrity in osteoarthritis.","date":"2023","source":"Annals of the rheumatic diseases","url":"https://pubmed.ncbi.nlm.nih.gov/37344157","citation_count":41,"is_preprint":false},{"pmid":"7689683","id":"PMC_7689683","title":"Diurnal expression of c-fos in the mouse retina.","date":"1993","source":"Brain research. Molecular brain research","url":"https://pubmed.ncbi.nlm.nih.gov/7689683","citation_count":41,"is_preprint":false},{"pmid":"8413289","id":"PMC_8413289","title":"UVB-induced DNA breaks interfere with transcriptional induction of c-fos.","date":"1993","source":"Molecular and cellular biology","url":"https://pubmed.ncbi.nlm.nih.gov/8413289","citation_count":40,"is_preprint":false},{"pmid":"24023832","id":"PMC_24023832","title":"C-Fos regulation by the MAPK and PKC pathways in intervertebral disc cells.","date":"2013","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/24023832","citation_count":39,"is_preprint":false},{"pmid":"15489021","id":"PMC_15489021","title":"Sensitivity to pain and c-Fos expression in brain structures in rats.","date":"2004","source":"Neuroscience letters","url":"https://pubmed.ncbi.nlm.nih.gov/15489021","citation_count":39,"is_preprint":false},{"pmid":"9671550","id":"PMC_9671550","title":"Regulation of c-fos expression by RNA polymerase elongation competence.","date":"1998","source":"Journal of molecular biology","url":"https://pubmed.ncbi.nlm.nih.gov/9671550","citation_count":39,"is_preprint":false},{"pmid":"8184987","id":"PMC_8184987","title":"c-fos antisense in rostral ventral medulla reduces arterial blood pressure.","date":"1994","source":"The American journal of physiology","url":"https://pubmed.ncbi.nlm.nih.gov/8184987","citation_count":39,"is_preprint":false},{"pmid":"15247511","id":"PMC_15247511","title":"Osteoclasts, mononuclear phagocytes, and c-Fos: new insight into osteoimmunology.","date":"2004","source":"The Keio journal of medicine","url":"https://pubmed.ncbi.nlm.nih.gov/15247511","citation_count":38,"is_preprint":false},{"pmid":"8706827","id":"PMC_8706827","title":"Selective uptake and degradation of c-Fos and v-Fos by rat liver lysosomes.","date":"1996","source":"FEBS letters","url":"https://pubmed.ncbi.nlm.nih.gov/8706827","citation_count":38,"is_preprint":false},{"pmid":"9950815","id":"PMC_9950815","title":"Gastrin induces c-fos gene transcription via multiple signaling pathways.","date":"1999","source":"The American journal of physiology","url":"https://pubmed.ncbi.nlm.nih.gov/9950815","citation_count":38,"is_preprint":false},{"pmid":"8904195","id":"PMC_8904195","title":"c-Fos expression during wakefulness and sleep.","date":"1995","source":"Neurophysiologie clinique = Clinical neurophysiology","url":"https://pubmed.ncbi.nlm.nih.gov/8904195","citation_count":35,"is_preprint":false},{"pmid":"18784083","id":"PMC_18784083","title":"c-Fos activates glucosylceramide synthase and glycolipid synthesis in PC12 cells.","date":"2008","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/18784083","citation_count":35,"is_preprint":false},{"pmid":"2469685","id":"PMC_2469685","title":"Elevated c-fos expression inhibits differentiation of L6 rat myoblasts.","date":"1989","source":"Journal of cellular physiology","url":"https://pubmed.ncbi.nlm.nih.gov/2469685","citation_count":35,"is_preprint":false},{"pmid":"25354492","id":"PMC_25354492","title":"Up-regulation of c-Fos associated with neuronal apoptosis following intracerebral hemorrhage.","date":"2014","source":"Cellular and molecular neurobiology","url":"https://pubmed.ncbi.nlm.nih.gov/25354492","citation_count":34,"is_preprint":false},{"pmid":"30624427","id":"PMC_30624427","title":"c-Fos and neuronal plasticity: the aftermath of Kaczmarek's theory.","date":"2018","source":"Acta neurobiologiae experimentalis","url":"https://pubmed.ncbi.nlm.nih.gov/30624427","citation_count":32,"is_preprint":false},{"pmid":"8274764","id":"PMC_8274764","title":"Circadian regulation of c-fos expression in the suprachiasmatic pacemaker by light.","date":"1993","source":"Journal of biological rhythms","url":"https://pubmed.ncbi.nlm.nih.gov/8274764","citation_count":32,"is_preprint":false},{"pmid":"12237184","id":"PMC_12237184","title":"Trigeminal c-Fos expression and behavioral responses to pulpal inflammation in ferrets.","date":"2002","source":"Pain","url":"https://pubmed.ncbi.nlm.nih.gov/12237184","citation_count":32,"is_preprint":false},{"pmid":"12064606","id":"PMC_12064606","title":"Regulation of connexin43 expression by c-fos and c-jun in myometrial cells.","date":"2001","source":"Cell communication & adhesion","url":"https://pubmed.ncbi.nlm.nih.gov/12064606","citation_count":32,"is_preprint":false},{"pmid":"20053986","id":"PMC_20053986","title":"Heterodimerization with different Jun proteins controls c-Fos intranuclear dynamics and distribution.","date":"2010","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/20053986","citation_count":32,"is_preprint":false},{"pmid":"17160021","id":"PMC_17160021","title":"N-Terminal c-Fos tyrosine phosphorylation regulates c-Fos/ER association and c-Fos-dependent phospholipid synthesis activation.","date":"2006","source":"Oncogene","url":"https://pubmed.ncbi.nlm.nih.gov/17160021","citation_count":31,"is_preprint":false},{"pmid":"8750937","id":"PMC_8750937","title":"c-fos expression as a marker of central cardiovascular neurons.","date":"1995","source":"Biological signals","url":"https://pubmed.ncbi.nlm.nih.gov/8750937","citation_count":30,"is_preprint":false},{"pmid":"21998197","id":"PMC_21998197","title":"c-Fos activates and physically interacts with specific enzymes of the pathway of synthesis of polyphosphoinositides.","date":"2011","source":"Molecular biology of the cell","url":"https://pubmed.ncbi.nlm.nih.gov/21998197","citation_count":30,"is_preprint":false},{"pmid":"22969311","id":"PMC_22969311","title":"c-fos and its Consequences in Pain.","date":"2002","source":"The Malaysian journal of medical sciences : MJMS","url":"https://pubmed.ncbi.nlm.nih.gov/22969311","citation_count":29,"is_preprint":false},{"pmid":"8601460","id":"PMC_8601460","title":"Expression of c-fos gene inhibits proteoglycan synthesis in transfected chondrocyte.","date":"1996","source":"FEBS letters","url":"https://pubmed.ncbi.nlm.nih.gov/8601460","citation_count":29,"is_preprint":false},{"pmid":"3131720","id":"PMC_3131720","title":"Enhancement of c-fos expression is associated with activated macrophages.","date":"1988","source":"Oncogene","url":"https://pubmed.ncbi.nlm.nih.gov/3131720","citation_count":29,"is_preprint":false},{"pmid":"9867253","id":"PMC_9867253","title":"c-Fos dimerization with c-Jun represses c-Jun enhancement of androgen receptor transactivation.","date":"1998","source":"Endocrine","url":"https://pubmed.ncbi.nlm.nih.gov/9867253","citation_count":28,"is_preprint":false},{"pmid":"26143639","id":"PMC_26143639","title":"Brain development is impaired in c-fos -/- mice.","date":"2015","source":"Oncotarget","url":"https://pubmed.ncbi.nlm.nih.gov/26143639","citation_count":28,"is_preprint":false},{"pmid":"29312525","id":"PMC_29312525","title":"MiR-30a attenuates osteoclastogenesis via targeting DC-STAMP-c-Fos-NFATc1 signaling.","date":"2017","source":"American journal of translational research","url":"https://pubmed.ncbi.nlm.nih.gov/29312525","citation_count":28,"is_preprint":false},{"pmid":"37564212","id":"PMC_37564212","title":"Protection of c-Fos from autophagic degradation by PRMT1-mediated methylation fosters gastric tumorigenesis.","date":"2023","source":"International journal of biological sciences","url":"https://pubmed.ncbi.nlm.nih.gov/37564212","citation_count":27,"is_preprint":false},{"pmid":"23919306","id":"PMC_23919306","title":"A mutation in the c-fos gene associated with congenital generalized lipodystrophy.","date":"2013","source":"Orphanet journal of rare diseases","url":"https://pubmed.ncbi.nlm.nih.gov/23919306","citation_count":27,"is_preprint":false},{"pmid":"17189721","id":"PMC_17189721","title":"Role of heterodimerization of c-Fos and Fra1 proteins in osteoclast differentiation.","date":"2006","source":"Bone","url":"https://pubmed.ncbi.nlm.nih.gov/17189721","citation_count":27,"is_preprint":false},{"pmid":"34610301","id":"PMC_34610301","title":"c-FOS drives reversible basal to squamous cell carcinoma transition.","date":"2021","source":"Cell reports","url":"https://pubmed.ncbi.nlm.nih.gov/34610301","citation_count":26,"is_preprint":false},{"pmid":"9247744","id":"PMC_9247744","title":"C-fos expression in central neurons mediating the arterial baroreceptor reflex.","date":"1997","source":"Clinical and experimental hypertension (New York, N.Y. : 1993)","url":"https://pubmed.ncbi.nlm.nih.gov/9247744","citation_count":26,"is_preprint":false},{"pmid":"8737385","id":"PMC_8737385","title":"C-fos and c-jun expression in human endometrium and myometrium.","date":"1996","source":"Molecular and cellular endocrinology","url":"https://pubmed.ncbi.nlm.nih.gov/8737385","citation_count":25,"is_preprint":false}],"cost":{"stage1":{"model":"claude-sonnet-4-6","input_tokens":44012,"output_tokens":8080,"usd":0.126618,"stage1_stop_reason":"end_turn"},"stage2":{"model":"claude-opus-4-8","input_tokens":17661,"output_tokens":7847,"usd":0.14224,"stage2_stop_reason":"end_turn"},"total_usd":0.268858,"stage1_batch_id":"msgbatch_01AsR7g8dGTEiEw9U83bJeWn","stage2_batch_id":"msgbatch_01YV5ZyxtFNUZEjxRcpd9jzb","note":"batch pricing = 50% of standard"},"stage1_raw":"```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 1992,\n      \"finding\": \"c-Fos is essential for osteoclast and bone development in vivo; c-fos knockout mice develop osteopetrosis with deficiencies in bone remodeling and altered haematopoiesis, defining c-Fos as a required transcription factor for specific cellular differentiation compartments.\",\n      \"method\": \"Gene targeting in embryonic stem cells; homozygous knockout mice phenotypic analysis\",\n      \"journal\": \"Nature\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — clean genetic knockout with defined multi-organ phenotype, replicated across multiple labs subsequently\",\n      \"pmids\": [\"1465144\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1986,\n      \"finding\": \"c-fos mRNA is required for normal cell division in 3T3 cells; inducible antisense RNA complementary to c-fos mRNA decreased colony formation and inhibited cell proliferation.\",\n      \"method\": \"Antisense RNA gene transfer with inducible MMTV promoter; colony formation and proliferation assays\",\n      \"journal\": \"Proceedings of the National Academy of Sciences of the United States of America\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — antisense knockdown with two orthogonal readouts (colony formation, proliferation), single lab\",\n      \"pmids\": [\"3523478\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1987,\n      \"finding\": \"c-fos mRNA undergoes rapid post-transcriptional degradation with a half-life of ~9 minutes, dependent on a destabilizing element in its 3' untranslated region; stabilization requires continued protein synthesis (cycloheximide blocks degradation).\",\n      \"method\": \"mRNA half-life measurements with 3' deletion/substitution mutants; cycloheximide treatment; Northern blot\",\n      \"journal\": \"Nucleic acids research\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Moderate — in vitro and cell-based mRNA stability assays with mutagenesis of 3' UTR, single lab but multiple orthogonal approaches\",\n      \"pmids\": [\"3103102\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1989,\n      \"finding\": \"c-Fos protein trans-represses its own promoter (c-fos autoregulation) through the serum response element (SRE); this trans-repression requires the leucine zipper (protein complex formation) but not AP-1/ATF sites, and is distinct from trans-activation.\",\n      \"method\": \"Transient transfection with Fos leucine zipper and DNA-binding mutants; reporter gene assays with c-fos promoter deletions\",\n      \"journal\": \"Cell\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Moderate — mutagenesis of functional domains combined with promoter reporter assays, mechanistic dissection of repression versus activation, single lab with multiple orthogonal constructs\",\n      \"pmids\": [\"2513130\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1988,\n      \"finding\": \"Mutations at the C-terminus of Fos protein (of the type found in virally-transduced transforming Fos variants) prevent rapid down-regulation of c-fos transcription following serum stimulation and act dominantly in trans to prevent down-regulation of a co-transfected c-fos gene.\",\n      \"method\": \"Transient co-transfection with C-terminal Fos mutants; run-on transcription assays\",\n      \"journal\": \"The EMBO journal\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 1 / Moderate — mutagenesis with functional transcriptional readout, dominant trans effect demonstrated, single lab\",\n      \"pmids\": [\"3149583\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1991,\n      \"finding\": \"c-Fos forms stable heterodimers with c-Jun, JunB, and JunD through their leucine zipper domains; heterodimers bind AP-1 sites and regulate transcription. c-Fos stimulates transcriptional activity of c-Jun heterodimers, whereas Fra-2 (and Fra-1) suppress c-Jun transactivation, with differences mapping to C-terminal regions.\",\n      \"method\": \"In vitro dimerization assays; gel shift/EMSA; transient transfection reporter assays; chimeric protein analysis\",\n      \"journal\": \"Nucleic acids research\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Moderate — in vitro reconstitution of heterodimers, DNA binding assays, and functional transactivation assays with chimeric proteins, single lab but multiple orthogonal methods\",\n      \"pmids\": [\"1945831\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1992,\n      \"finding\": \"c-Fos stability is regulated by dimerization with phosphorylated c-Jun: phosphorylated c-Jun targets c-Fos for degradation in a signal-dependent manner, whereas phorbol ester-induced (dephosphorylated) c-Jun stabilizes c-Fos. v-Fos is not susceptible to c-Jun-targeted degradation.\",\n      \"method\": \"Transient expression assays; in vitro degradation experiments with phosphorylated vs. unphosphorylated c-Jun\",\n      \"journal\": \"Science\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Moderate — in vitro degradation reconstitution plus cell-based transient expression, mechanistic dissection with phosphorylation state manipulation, single lab\",\n      \"pmids\": [\"1470918\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1996,\n      \"finding\": \"c-Fos is phosphorylated by MAP kinase and RSK at serines 362 and 374 (rat) in vivo during early G1; phosphorylation-mimicking mutations (S→D) increase c-Fos stability and AP-1 transactivation activity, whereas alanine substitutions reduce stability, indicating phosphorylation supports proliferative responses.\",\n      \"method\": \"In vitro kinase assays with MAP kinase and RSK; site-directed mutagenesis (Asp/Ala substitutions); AP-1 reporter assays; protein half-life measurements\",\n      \"journal\": \"Oncogene\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — in vitro kinase assay plus mutagenesis plus functional (transactivation, transformation, stability) readouts, multiple orthogonal methods in single study\",\n      \"pmids\": [\"8622865\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1996,\n      \"finding\": \"c-Fos protein can induce apoptosis in preneoplastic cells in a manner that does not require new protein synthesis, does not involve its transcriptional activation activity (v-Fos which is transcriptionally active but lacks repression activity fails to induce apoptosis), and is blocked by Bcl-2 overexpression and requires p53.\",\n      \"method\": \"Chimeric c-FosER fusion protein activation; cycloheximide treatment; Bcl-2 co-expression; p53-null cell lines and HPV E6-mediated p53 knockdown; apoptosis assays\",\n      \"journal\": \"Molecular and cellular biology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — multiple cell lines and genetic manipulations in single lab, but complex interpretation; v-Fos comparison provides mechanistic separation of activities\",\n      \"pmids\": [\"8524298\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2001,\n      \"finding\": \"c-Fos associates with the endoplasmic reticulum and activates phospholipid metabolism by an AP-1-independent cytoplasmic activity; two waves of c-Fos expression stimulate sequential synthesis of signaling polyphosphoinositides then membrane-biogenesis phospholipids; a peptide blocking AP-1 nuclear import does not affect this lipid activation.\",\n      \"method\": \"32P-orthophosphate incorporation into lipid fractions; immunocytochemistry showing ER localization; AP-1 nuclear import blockade peptide; timing of c-Fos expression waves\",\n      \"journal\": \"FASEB journal\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — direct ER localization by immunocytochemistry plus lipid labeling assays with AP-1 independence demonstrated, single lab\",\n      \"pmids\": [\"11259365\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2006,\n      \"finding\": \"c-Fos/ER association and cytoplasmic phospholipid synthesis activation are regulated by the phosphorylation state of c-Fos N-terminal tyrosine residues 10 and 30: tyrosine-phosphorylated c-Fos is not ER-membrane bound, while dephosphorylated c-Fos associates with the ER and promotes phospholipid synthesis.\",\n      \"method\": \"Site-directed mutagenesis of tyrosine residues; subcellular fractionation; 32P-lipid labeling; phosphotyrosine immunoblotting; cell proliferation assays\",\n      \"journal\": \"Oncogene\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — mutagenesis of specific tyrosine residues with functional lipid synthesis readout and subcellular localization, single lab\",\n      \"pmids\": [\"17160021\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2008,\n      \"finding\": \"c-Fos activates glucosylceramide synthase (GlcCerS) and glycolipid synthesis in PC12 cells; c-Fos physically interacts with GlcCerS as demonstrated by co-immunoprecipitation, and activates its enzymatic activity without affecting downstream glycolipid synthesis enzymes.\",\n      \"method\": \"Metabolic labeling of glycolipids; co-immunoprecipitation of c-Fos with V5-tagged GlcCerS; enzymatic activity assays for GlcCerS and downstream enzymes\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — Co-IP plus enzyme activity assays, single lab, two orthogonal methods\",\n      \"pmids\": [\"18784083\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2011,\n      \"finding\": \"c-Fos physically interacts with and activates CDP-diacylglycerol synthase and phosphatidylinositol 4-kinase IIα (but not PtdIns synthase or PtdIns 4-kinase IIβ) via its N-terminal domain, stimulating polyphosphoinositide synthesis; interaction confirmed by co-immunoprecipitation and FRET.\",\n      \"method\": \"In vitro enzyme activity assays; co-immunoprecipitation; FRET (fluorescence resonance energy transfer); N-terminal domain truncation constructs\",\n      \"journal\": \"Molecular biology of the cell\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Moderate — in vitro enzyme assays, co-IP, and FRET showing physical interaction, domain mapping, multiple orthogonal methods in single study\",\n      \"pmids\": [\"21998197\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1991,\n      \"finding\": \"c-Fos and c-Jun are substrates for calpain (calcium-dependent neutral protease) in vitro; calpain efficiently digests both proteins, and c-Jun calpain activity can be modified in vivo by manipulating calpastatin (endogenous calpain inhibitor) levels.\",\n      \"method\": \"In vitro calpain digestion assay; calpastatin overexpression/manipulation in cultured cells\",\n      \"journal\": \"FEBS letters\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 1 / Moderate — in vitro biochemical assay plus cell-based validation, single lab\",\n      \"pmids\": [\"1908791\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1996,\n      \"finding\": \"Lysosomes selectively take up and degrade c-Fos in a cell-free assay; lysosomal uptake of c-Fos is regulated by dimerization with differentially phosphorylated c-Jun, and c-Fos is immunologically detected in leupeptin-treated rat liver lysosomes in vivo, while v-Fos escapes this regulation.\",\n      \"method\": \"Cell-free lysosome uptake/degradation assay; immunological detection of c-Fos in purified lysosomes from leupeptin-treated rats\",\n      \"journal\": \"FEBS letters\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 1 / Moderate — cell-free reconstitution plus in vivo lysosomal detection, single lab, two orthogonal approaches\",\n      \"pmids\": [\"8706827\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2004,\n      \"finding\": \"JNK-mediated phosphorylation of newly synthesized c-Fos at serine residues protects c-Fos from proteasomal degradation in cardiomyocytes; dephosphorylation by PP2A (but not PP2B/calcineurin) triggers ubiquitin-dependent proteasomal degradation of c-Fos.\",\n      \"method\": \"Pharmacological JNK inhibitor; proteasome inhibitors (MG132, PI-1); PP2A and PP2B phosphatase treatment of immunoprecipitated c-Fos; phosphoserine/threonine immunoblotting; ubiquitin immunoprecipitation\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Moderate — multiple pharmacological and biochemical approaches with mechanistic dissection of kinase/phosphatase regulation of proteasomal degradation in single study\",\n      \"pmids\": [\"15136564\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1993,\n      \"finding\": \"MyoD binds a site overlapping the serum response element (SRE) in the c-fos promoter and acts as a negative transcriptional regulator of c-fos, blocking serum responsiveness; this identifies a mechanism by which MyoD can inhibit growth-responsive gene expression during muscle differentiation.\",\n      \"method\": \"Promoter deletion/mutation analysis; gel shift assays identifying MyoD binding site; transient transfection reporter assays in muscle cells\",\n      \"journal\": \"Nature\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 1 / Moderate — promoter mutagenesis, gel-shift identification of binding site, and functional reporter assays, single lab\",\n      \"pmids\": [\"8386804\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2002,\n      \"finding\": \"c-Fos regulates neuronal excitability and survival by controlling expression of the kainic acid receptor GluR6 and BDNF; hippocampus-specific c-fos knockout mice show increased kainic acid-induced seizures, neuronal excitability, and neuronal death.\",\n      \"method\": \"Conditional hippocampus-specific c-fos knockout mice; kainic acid-induced seizure model; in vivo and in vitro gene expression analysis of GluR6 and BDNF\",\n      \"journal\": \"Nature genetics\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — conditional KO with defined neuronal phenotype plus identification of downstream target genes (GluR6, BDNF) in vivo and in vitro, multiple orthogonal readouts\",\n      \"pmids\": [\"11925568\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2006,\n      \"finding\": \"c-Fos produced in D1 receptor-expressing neurons regulates acquisition and extinction of cocaine-induced persistent changes; c-Fos-deficient neurons show altered expression of transcription factors, neurotransmitter receptors, and intracellular signaling molecules, and blunted dendritic remodeling of medium spiny neurons after repeated cocaine.\",\n      \"method\": \"Neuron-specific (D1 receptor-expressing) c-fos conditional knockout mice; cocaine sensitization and conditioned place preference behavioral tests; Western blot and immunohistochemistry for downstream targets; dendritic morphology analysis\",\n      \"journal\": \"The Journal of neuroscience\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — conditional cell-type-specific KO with multiple molecular and behavioral readouts, single lab but multiple orthogonal methods\",\n      \"pmids\": [\"17182779\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2003,\n      \"finding\": \"STAT3 (but not STAT1) accumulates on the chromosomal c-fos promoter and independently boosts transcription; STAT3 cooperates with resident nuclear proteins (ELK1) activated by MAPK pathways to produce additive transcriptional increases, acting on the native chromosomal gene.\",\n      \"method\": \"Chromatin immunoprecipitation (ChIP) on endogenous c-fos promoter; transient transfection with STAT3/STAT1; luciferase reporter assays\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — ChIP on endogenous chromosomal gene plus reporter assays, single lab, two orthogonal methods\",\n      \"pmids\": [\"12600988\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2003,\n      \"finding\": \"The MEK5-ERK5 pathway phosphorylates and stabilizes c-Fos at sites distinct from those phosphorylated by ERK1/2, and the C-terminal half of ERK5 is required for maximal activation of c-Fos transactivation activity.\",\n      \"method\": \"In vitro kinase assays; dominant-negative and constitutively active MEK5/ERK5 constructs; c-Fos stability/phosphorylation assays; AP-1 reporter assays\",\n      \"journal\": \"Genes to cells\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 1 / Moderate — in vitro kinase assay plus cell-based phosphorylation and transactivation assays, single lab\",\n      \"pmids\": [\"12622723\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2010,\n      \"finding\": \"c-Fos intranuclear mobility and distribution are differentially regulated by its Jun dimerization partners: heterodimerization with c-Jun causes dramatic reduction in c-Fos nuclear mobility and redistribution to the nuclear matrix independently of AP-1/CRE DNA binding, while dimerization with JunB does not affect c-Fos mobility but alters its intranuclear distribution differently.\",\n      \"method\": \"FRAP (fluorescence recovery after photobleaching); co-immunoprecipitation; subcellular fractionation; fluorescent protein fusions; genetic mutants lacking DNA-binding capacity\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — FRAP live-cell imaging, co-IP, fractionation, and domain mutants all converging on same mechanistic conclusion, single lab but multiple orthogonal methods\",\n      \"pmids\": [\"20053986\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1998,\n      \"finding\": \"c-Fos dimerization with c-Jun (through the leucine zipper) represses c-Jun-mediated enhancement of androgen receptor transactivation; the bZIP leucine zipper (dimerization) domain of c-Fos is required and sufficient for this inhibition, while DNA binding is dispensable.\",\n      \"method\": \"Transient transfection reporter assays with c-Fos truncation mutants; hKLK2 promoter-luciferase constructs\",\n      \"journal\": \"Endocrine\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — systematic truncation mutagenesis with functional transcriptional readout, single lab\",\n      \"pmids\": [\"9867253\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2001,\n      \"finding\": \"c-Fos and c-Jun co-activate connexin43 (Cx43) promoter through an AP-1 site; mutation of the AP-1 site reduces this responsiveness, identifying Cx43 as a direct transcriptional target of c-Fos/c-Jun AP-1 complexes in myometrial cells.\",\n      \"method\": \"Transient co-transfection with c-Fos and c-Jun expression vectors; Cx43 promoter-luciferase reporter; AP-1 site mutation\",\n      \"journal\": \"Cell communication & adhesion\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Weak — single promoter reporter assay with AP-1 site mutagenesis, single lab, single method\",\n      \"pmids\": [\"12064606\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2013,\n      \"finding\": \"TLR7 negatively regulates dendrite outgrowth through a Myd88-c-Fos-IL-6 signaling pathway; TLR7 activation induces IL-6 through Myd88, and c-Fos is required for this pathway as shown by genetic knockouts of Myd88 and IL-6.\",\n      \"method\": \"In vitro neuronal cultures; in utero electroporation; Myd88-/-, IL-6-/-, TNFα-/- neurons; TLR7 agonist treatments; dendrite morphology quantification\",\n      \"journal\": \"The Journal of neuroscience\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — genetic epistasis with multiple KO neurons and pharmacological TLR7 agonists, single lab, pathway position defined\",\n      \"pmids\": [\"23843519\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2021,\n      \"finding\": \"MEF2C directly binds FOS regulatory regions to induce c-FOS expression, which then activates NFATc1 and drives osteoclastogenesis; MEF2C-mediated c-FOS induction is required for RANKL-induced osteoclast differentiation.\",\n      \"method\": \"ChIP assay showing MEF2C binding to FOS regulatory regions; MEF2C ectopic expression and knockdown; conditional Mef2c knockout mice; osteoclastogenesis assays; transcriptomic analysis\",\n      \"journal\": \"Bone research\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — ChIP identifying direct binding site, conditional KO mice, ectopic expression/knockdown, and transcriptomic data converge on same pathway conclusion\",\n      \"pmids\": [\"33424022\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2006,\n      \"finding\": \"A single c-Jun/c-Fos AP-1 dimer is sufficient for osteoclast differentiation from c-Fos-deficient hematopoietic precursors; c-Fos heterodimerized with any Jun protein (including JNK-phosphorylation-site mutant c-Jun) rescues osteoclastogenesis, but Fra1 with any Jun protein cannot rescue, suggesting c-Fos has broader AP-1 site transactivation capability required for osteoclast differentiation.\",\n      \"method\": \"Synthetic single-chain AP-1 dimers (tethered via linker); rescue of osteoclastogenesis from c-Fos-deficient precursors; transient transfection AP-1 reporter assays\",\n      \"journal\": \"Bone\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — reconstitution of function with defined synthetic dimers, systematic comparison of Fos/Fra1 with multiple Jun partners, genetic rescue in c-Fos-null background\",\n      \"pmids\": [\"17189721\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2023,\n      \"finding\": \"c-Fos modulates cellular bioenergetics in chondrocytes by balancing pyruvate flux between anaerobic glycolysis and the TCA cycle; cartilage-specific c-Fos knockout mice show decreased pyruvate dehydrogenase (Pdh) activity, elevated lactate dehydrogenase (Ldh) activity, and elevated HIF-1α/Pdk1/Ldha expression, with exacerbated OA. DCA (Pdk inhibitor) treatment rescues these metabolic and structural defects.\",\n      \"method\": \"Cartilage-specific conditional c-fos knockout (c-FosΔCh); DMM OA model; RNA-seq; in situ metabolic enzyme activity assays for Pdh and Ldh; DCA pharmacological rescue\",\n      \"journal\": \"Annals of the rheumatic diseases\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — conditional KO, in situ enzyme assays, RNA-seq, and pharmacological rescue all in same study establishing c-Fos as metabolic regulator in chondrocytes\",\n      \"pmids\": [\"37344157\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2023,\n      \"finding\": \"PRMT1 directly interacts with c-Fos and methylates it at arginine 287 (mono- and dimethylation), protecting c-Fos from autophagic degradation and enhancing AP-1 transcriptional activity; PRMT1 knockdown decreases c-Fos protein levels, and R287 methylation promotes c-Fos protein stabilization.\",\n      \"method\": \"Co-immunoprecipitation; mass spectrometry identification of methylation sites; PRMT1 knockdown; autophagy inhibition experiments; AP-1 reporter assays\",\n      \"journal\": \"International journal of biological sciences\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — Co-IP, MS identification of modification site, functional rescue experiments; single lab with multiple methods but full mutagenesis validation not explicitly described in abstract\",\n      \"pmids\": [\"37564212\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2015,\n      \"finding\": \"During MAPK induction, transcription factor concentration modulates the burst frequency of c-Fos transcription; the polymerase initiation frequency is linked to transactivation domain strength, and burst duration is linked to TF lifetime on the promoter, as shown using synthetic TALE-based TFs.\",\n      \"method\": \"Single-molecule FISH (smFISH) with computational modeling; synthetic TALE transcription factors targeting c-Fos promoter; quantification at individual endogenous alleles\",\n      \"journal\": \"Cell reports\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — quantitative single-molecule imaging at endogenous locus combined with synthetic TF engineering and computational modeling, multiple orthogonal approaches in single study\",\n      \"pmids\": [\"24981864\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2015,\n      \"finding\": \"Multiple enhancers surrounding the c-fos gene are required for robust c-fos response to various stimuli; membrane depolarization, BDNF, and forskolin activate distinct subsets of enhancers to induce c-fos transcription in neurons, with different key transcription factors required depending on the type of stimulation.\",\n      \"method\": \"Enhancer deletion/mutation analysis; luciferase reporter assays; ChIP; neuronal stimulation with defined stimuli; in vivo brain activation\",\n      \"journal\": \"Nature neuroscience\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — systematic enhancer functional mapping with multiple stimuli, ChIP, and in vivo validation, demonstrating stimulus-specific combinatorial enhancer activation\",\n      \"pmids\": [\"26595656\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2021,\n      \"finding\": \"c-FOS drives basal to squamous cell carcinoma transition (BST) by regulating the accessibility of distinct AP-1 regulatory elements; c-FOS-mediated BST is reversible, and EGFR pathway blockade after c-FOS induction reverts BST in vitro and prevents BST features in mouse models and human tumors.\",\n      \"method\": \"Inducible c-FOS expression systems; ATAC-seq/chromatin accessibility assays; EGFR inhibitor treatment; mouse models; patient single-cell and bulk transcriptomics\",\n      \"journal\": \"Cell reports\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — inducible expression system with chromatin accessibility readout and in vivo rescue, single lab\",\n      \"pmids\": [\"34610301\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1998,\n      \"finding\": \"RNA polymerases are constitutively engaged at the c-fos promoter-proximal region in the absence of activation signals but terminate close to the promoter; activation of c-fos expression results primarily from assembly of elongation-competent RNA polymerases that can transcribe the complete gene, establishing transcription elongation as a key regulatory step.\",\n      \"method\": \"Nuclear run-on transcription analysis at nucleotide resolution in intact cells; promoter occupancy and chromatin conformation analysis\",\n      \"journal\": \"Journal of molecular biology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 1 / Moderate — high-resolution nuclear run-on mapping in intact cells, single lab, mechanistic dissection of elongation vs. initiation regulation\",\n      \"pmids\": [\"9671550\"],\n      \"is_preprint\": false\n    }\n  ],\n  \"current_model\": \"c-Fos is a bZIP transcription factor that heterodimerizes with Jun family proteins via a leucine zipper to form AP-1 complexes that bind promoter AP-1 sites and regulate gene transcription; it autoregulates its own promoter through the SRE, undergoes rapid mRNA decay (~9 min half-life) via a 3'-UTR destabilizing element, and is post-translationally regulated by phosphorylation (by MAP kinase/RSK stabilizing, JNK-mediated serine phosphorylation protecting from proteasomal degradation, and tyrosine dephosphorylation enabling ER association) and arginine methylation by PRMT1 (protecting from autophagic degradation); in addition to nuclear transcription factor activity, c-Fos localizes to the ER where it activates phospholipid and glycolipid synthesis enzymes (CDP-diacylglycerol synthase, PtdIns 4-kinase IIα, glucosylceramide synthase) via direct physical interaction; c-Fos is essential in vivo for osteoclast differentiation (where it acts upstream of NFATc1 and is induced by MEF2C), neuronal excitability/survival (regulating GluR6 and BDNF expression), chondrocyte metabolic homeostasis (balancing pyruvate flux between glycolysis and TCA cycle), and normal brain development.\"\n}\n```","stage2_raw":"{\n  \"mechanistic_narrative\": \"c-Fos is an immediate-early gene product that functions as a bZIP transcription factor, dimerizing with c-Jun, JunB, and JunD through its leucine zipper to form AP-1 complexes that bind AP-1 sites and regulate transcription [#5]; c-Jun heterodimers also remodel c-Fos nuclear mobility and redistribute it to the nuclear matrix independently of DNA binding [#21]. Its own expression is tightly controlled at multiple levels: transcription is governed by stimulus-specific enhancer subsets and SRE/STAT3/ELK1 inputs, with regulation occurring substantially at the elongation step where promoter-proximal polymerases must be converted to elongation-competent forms, and transactivation strength setting transcriptional burst kinetics [#19, #29, #30, #32]; c-Fos additionally trans-represses its own promoter through the SRE via its leucine zipper, a function distinct from AP-1 transactivation [#3]. The mRNA is intrinsically unstable (~9 min half-life) through a 3'-UTR destabilizing element [#2]. c-Fos protein stability is set by a network of post-translational signals: MAPK/RSK and MEK5-ERK5 phosphorylation stabilize it and boost AP-1 activity, JNK serine phosphorylation protects it from PP2A-dependent proteasomal degradation, PRMT1-mediated arginine-287 methylation protects it from autophagic degradation, and dimerization with phosphorylated c-Jun targets it for degradation [#7, #20, #15, #28, #6]. Beyond nuclear transcription, dephosphorylated (tyrosine-10/30) c-Fos associates with the endoplasmic reticulum, where it directly binds and activates lipid-synthesis enzymes — CDP-diacylglycerol synthase, PtdIns 4-kinase IIα, and glucosylceramide synthase — to drive phospholipid and glycolipid synthesis in an AP-1-independent manner [#9, #10, #11, #12]. In vivo, c-Fos is essential for osteoclast differentiation, acting downstream of MEF2C and upstream of NFATc1 [#0, #25, #26], for neuronal excitability and survival via control of GluR6 and BDNF and for cocaine-induced neuronal plasticity [#17, #18], and for chondrocyte bioenergetic homeostasis by balancing pyruvate flux between glycolysis and the TCA cycle [#27].\",\n  \"teleology\": [\n    {\n      \"year\": 1986,\n      \"claim\": \"Established that c-fos is functionally required for cell proliferation rather than being a passive marker of mitogenic stimulation.\",\n      \"evidence\": \"Inducible antisense c-fos RNA in 3T3 cells with colony-formation and proliferation readouts\",\n      \"pmids\": [\"3523478\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Antisense knockdown does not define which target genes mediate the proliferative effect\", \"Single cell type\"]\n    },\n    {\n      \"year\": 1987,\n      \"claim\": \"Defined the basis of c-fos transience by localizing an mRNA destabilizing element to the 3' UTR, explaining its immediate-early kinetics.\",\n      \"evidence\": \"mRNA half-life measurements with 3' UTR deletion/substitution mutants and cycloheximide treatment\",\n      \"pmids\": [\"3103102\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Trans-acting decay factors not identified\", \"Link between protein synthesis requirement and decay machinery unresolved\"]\n    },\n    {\n      \"year\": 1988,\n      \"claim\": \"Identified the Fos C-terminus as the determinant of transcriptional autodownregulation, distinguishing oncogenic from normal Fos.\",\n      \"evidence\": \"Co-transfection of C-terminal Fos mutants with run-on transcription assays\",\n      \"pmids\": [\"3149583\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Molecular mechanism of the C-terminal effect not defined\", \"Single transient system\"]\n    },\n    {\n      \"year\": 1989,\n      \"claim\": \"Separated c-Fos's repression of its own promoter from its activation function, showing autorepression requires dimerization but not DNA binding.\",\n      \"evidence\": \"Leucine zipper and DNA-binding mutants with c-fos promoter reporter assays\",\n      \"pmids\": [\"2513130\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Identity of the partner protein mediating SRE-based repression unresolved\", \"Endogenous chromosomal relevance not tested here\"]\n    },\n    {\n      \"year\": 1991,\n      \"claim\": \"Defined c-Fos and c-Jun as calpain substrates, introducing proteolysis as a route to limit AP-1 factor lifetime.\",\n      \"evidence\": \"In vitro calpain digestion plus calpastatin manipulation in cells\",\n      \"pmids\": [\"1908791\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Physiological significance of calpain cleavage of c-Fos in vivo not established\", \"Cleavage sites not mapped\"]\n    },\n    {\n      \"year\": 1991,\n      \"claim\": \"Established the AP-1 dimer logic by defining c-Fos as a Jun heterodimerization partner that activates, while Fra proteins suppress, Jun transactivation.\",\n      \"evidence\": \"In vitro dimerization, EMSA, and reporter assays with chimeric proteins\",\n      \"pmids\": [\"1945831\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Genome-wide target spectrum not addressed\", \"C-terminal regions mapped only functionally\"]\n    },\n    {\n      \"year\": 1992,\n      \"claim\": \"Demonstrated in vivo that c-Fos is indispensable for osteoclast-mediated bone remodeling, anchoring its differentiation role in a defined lineage.\",\n      \"evidence\": \"Homozygous c-fos knockout mice with osteopetrosis phenotype\",\n      \"pmids\": [\"1465144\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Downstream transcriptional targets in osteoclasts not identified at the time\", \"Mechanism of lineage specificity unresolved\"]\n    },\n    {\n      \"year\": 1992,\n      \"claim\": \"Linked c-Fos turnover to its dimerization partner's phosphorylation state, coupling signaling to AP-1 factor degradation.\",\n      \"evidence\": \"In vitro degradation and transient expression with phosphorylated vs. dephosphorylated c-Jun\",\n      \"pmids\": [\"1470918\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Degradation pathway (proteasomal vs lysosomal) not yet assigned\", \"Phospho-sites on Jun driving the effect not mapped\"]\n    },\n    {\n      \"year\": 1993,\n      \"claim\": \"Showed MyoD represses c-fos via an SRE-overlapping site, mechanistically connecting muscle differentiation to shut-off of growth-responsive genes.\",\n      \"evidence\": \"Promoter mutagenesis, gel shift, and reporter assays in muscle cells\",\n      \"pmids\": [\"8386804\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Endogenous chromosomal occupancy not shown\", \"Generality beyond muscle cells untested\"]\n    },\n    {\n      \"year\": 1996,\n      \"claim\": \"Mapped MAPK/RSK phosphorylation of c-Fos serines and tied it to increased stability and AP-1 activity during G1, defining a proliferative regulatory switch.\",\n      \"evidence\": \"In vitro kinase assays, Asp/Ala mutagenesis, half-life and AP-1 reporter assays\",\n      \"pmids\": [\"8622865\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Degradation machinery acted upon by phosphorylation not defined here\", \"In vivo relevance of specific sites not tested\"]\n    },\n    {\n      \"year\": 1996,\n      \"claim\": \"Revealed a transcription-independent pro-apoptotic activity of c-Fos requiring p53 and blockable by Bcl-2, separating it from AP-1 transactivation.\",\n      \"evidence\": \"c-FosER chimera activation in p53-null and Bcl-2-expressing cells with cycloheximide\",\n      \"pmids\": [\"8524298\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Molecular effector of the apoptotic activity not identified\", \"Complex interpretation across multiple manipulations\"]\n    },\n    {\n      \"year\": 1996,\n      \"claim\": \"Identified lysosomal selective degradation of c-Fos regulated by Jun dimerization, broadening the routes controlling c-Fos lifetime.\",\n      \"evidence\": \"Cell-free lysosome uptake assay and in vivo detection in leupeptin-treated rat liver lysosomes\",\n      \"pmids\": [\"8706827\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Targeting signal directing c-Fos to lysosomes not defined\", \"Relative contribution vs proteasomal/autophagic pathways unclear\"]\n    },\n    {\n      \"year\": 1998,\n      \"claim\": \"Defined c-fos transcriptional control as primarily an elongation checkpoint, showing engaged polymerases terminate near the promoter until activation.\",\n      \"evidence\": \"Nucleotide-resolution nuclear run-on in intact cells\",\n      \"pmids\": [\"9671550\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Factors driving the elongation switch not identified\", \"Single-gene resolution limited to one system\"]\n    },\n    {\n      \"year\": 1998,\n      \"claim\": \"Showed c-Fos can inhibit nuclear receptor signaling by sequestering c-Jun through its leucine zipper, a DNA-binding-independent repression.\",\n      \"evidence\": \"c-Fos truncation mutants with androgen-responsive promoter reporters\",\n      \"pmids\": [\"9867253\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Endogenous AR target relevance not tested\", \"Single reporter system\"]\n    },\n    {\n      \"year\": 2001,\n      \"claim\": \"Discovered a cytoplasmic, AP-1-independent c-Fos function at the ER activating phospholipid synthesis, extending its role beyond transcription.\",\n      \"evidence\": \"32P-lipid labeling, ER immunocytochemistry, and AP-1 nuclear-import blockade peptide\",\n      \"pmids\": [\"11259365\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Direct enzyme targets not yet identified in this study\", \"Mechanism of ER recruitment unresolved\"]\n    },\n    {\n      \"year\": 2001,\n      \"claim\": \"Identified connexin43 as a direct AP-1 target of c-Fos/c-Jun, providing a concrete transcriptional output.\",\n      \"evidence\": \"Co-transfection with Cx43 promoter reporter and AP-1 site mutation\",\n      \"pmids\": [\"12064606\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Single reporter assay without endogenous chromatin validation\", \"Cell-type generality untested\"]\n    },\n    {\n      \"year\": 2002,\n      \"claim\": \"Established a neuronal in vivo role for c-Fos in controlling excitability and survival through GluR6 and BDNF target regulation.\",\n      \"evidence\": \"Hippocampus-specific conditional c-fos knockout in a kainic acid seizure model\",\n      \"pmids\": [\"11925568\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Direct vs indirect regulation of GluR6/BDNF not fully separated\", \"AP-1 site occupancy at these targets not shown\"]\n    },\n    {\n      \"year\": 2003,\n      \"claim\": \"Showed STAT3 and ELK1 cooperate on the endogenous c-fos promoter, integrating cytokine and MAPK inputs at the native chromosomal gene.\",\n      \"evidence\": \"ChIP on endogenous c-fos promoter plus reporter assays\",\n      \"pmids\": [\"12600988\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Mechanism of STAT3-ELK1 additive cooperation not resolved\", \"Single lab\"]\n    },\n    {\n      \"year\": 2003,\n      \"claim\": \"Identified a distinct MEK5-ERK5 phosphorylation input stabilizing c-Fos and boosting its transactivation, separate from ERK1/2 sites.\",\n      \"evidence\": \"In vitro kinase assays with dominant-negative/constitutive MEK5/ERK5 and AP-1 reporters\",\n      \"pmids\": [\"12622723\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Exact ERK5 phosphosites not mapped\", \"In vivo significance untested\"]\n    },\n    {\n      \"year\": 2004,\n      \"claim\": \"Resolved the degradation logic by showing JNK serine phosphorylation protects newly synthesized c-Fos from PP2A-triggered, ubiquitin-dependent proteasomal degradation.\",\n      \"evidence\": \"JNK/proteasome inhibitors, PP2A/PP2B treatment of immunoprecipitated c-Fos, ubiquitin IP in cardiomyocytes\",\n      \"pmids\": [\"15136564\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"E3 ligase mediating c-Fos ubiquitination not identified\", \"Phosphosites protected by JNK not precisely mapped\"]\n    },\n    {\n      \"year\": 2006,\n      \"claim\": \"Linked c-Fos tyrosine phosphorylation state to ER association, showing dephosphorylation of Tyr10/30 enables the lipid-synthesis activity.\",\n      \"evidence\": \"Tyrosine mutagenesis, subcellular fractionation, and 32P-lipid labeling\",\n      \"pmids\": [\"17160021\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Kinase/phosphatase controlling Tyr10/30 not identified\", \"Structural basis of ER membrane binding unknown\"]\n    },\n    {\n      \"year\": 2006,\n      \"claim\": \"Demonstrated that a single c-Jun/c-Fos AP-1 dimer suffices for osteoclastogenesis and that c-Fos cannot be substituted by Fra1, defining functional specificity within AP-1.\",\n      \"evidence\": \"Synthetic single-chain AP-1 dimers rescuing osteoclastogenesis from c-Fos-null precursors\",\n      \"pmids\": [\"17189721\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Molecular basis of c-Fos vs Fra1 transactivation difference not defined\", \"Specific osteoclast target genes not enumerated\"]\n    },\n    {\n      \"year\": 2006,\n      \"claim\": \"Extended the neuronal role of c-Fos to behavioral plasticity, showing D1-neuron c-Fos is required for cocaine-induced dendritic remodeling and gene expression changes.\",\n      \"evidence\": \"D1-neuron conditional c-fos knockout with behavioral, molecular, and dendritic readouts\",\n      \"pmids\": [\"17182779\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Direct c-Fos target genes driving remodeling not pinned down\", \"Circuit-level mechanism unresolved\"]\n    },\n    {\n      \"year\": 2008,\n      \"claim\": \"Identified glucosylceramide synthase as a direct c-Fos-interacting enzyme activated to drive glycolipid synthesis, broadening the ER lipid-activation program.\",\n      \"evidence\": \"Glycolipid metabolic labeling, co-IP with tagged GlcCerS, and enzyme activity assays in PC12 cells\",\n      \"pmids\": [\"18784083\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Mechanism of enzymatic activation not defined\", \"Single cell type\"]\n    },\n    {\n      \"year\": 2010,\n      \"claim\": \"Revealed that Jun partner identity controls c-Fos nuclear dynamics and matrix localization independently of DNA binding, adding a spatial layer to AP-1 regulation.\",\n      \"evidence\": \"FRAP, co-IP, fractionation, and DNA-binding mutants\",\n      \"pmids\": [\"20053986\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Functional consequence of nuclear matrix redistribution for target gene output unclear\", \"Matrix-anchoring partners not identified\"]\n    },\n    {\n      \"year\": 2011,\n      \"claim\": \"Established direct physical and functional engagement of c-Fos with CDP-diacylglycerol synthase and PtdIns 4-kinase IIα via its N-terminus, mechanistically grounding the ER lipid-synthesis role.\",\n      \"evidence\": \"In vitro enzyme assays, co-IP, FRET, and N-terminal truncations\",\n      \"pmids\": [\"21998197\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Structural model of c-Fos-enzyme complexes lacking\", \"How nuclear vs ER c-Fos pools are partitioned unresolved\"]\n    },\n    {\n      \"year\": 2015,\n      \"claim\": \"Connected transcription factor concentration and transactivation strength to the burst kinetics of c-fos transcription at single endogenous alleles.\",\n      \"evidence\": \"smFISH with synthetic TALE transcription factors and computational modeling\",\n      \"pmids\": [\"24981864\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Endogenous TFs setting burst behavior not exhaustively defined\", \"Link to chromatin state not addressed\"]\n    },\n    {\n      \"year\": 2015,\n      \"claim\": \"Defined stimulus-specific combinatorial enhancer usage controlling c-fos induction in neurons, explaining context-dependent activation.\",\n      \"evidence\": \"Enhancer deletion/mutation, reporters, ChIP, and in vivo brain activation\",\n      \"pmids\": [\"26595656\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Full TF complement at each enhancer not enumerated\", \"Mechanism of enhancer-promoter selectivity unresolved\"]\n    },\n    {\n      \"year\": 2021,\n      \"claim\": \"Placed c-FOS upstream in osteoclastogenesis as the MEF2C-induced activator of NFATc1, completing a defined RANKL-responsive transcriptional cascade.\",\n      \"evidence\": \"ChIP of MEF2C at FOS, conditional Mef2c knockout mice, expression manipulation, and transcriptomics\",\n      \"pmids\": [\"33424022\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Direct c-FOS occupancy at Nfatc1 not detailed here\", \"Co-factors at FOS regulatory regions not fully mapped\"]\n    },\n    {\n      \"year\": 2021,\n      \"claim\": \"Showed c-FOS drives a reversible basal-to-squamous carcinoma transition by remodeling AP-1 element accessibility, linking it to malignant cell-state plasticity.\",\n      \"evidence\": \"Inducible c-FOS, ATAC-seq, EGFR inhibition, mouse models, and patient transcriptomics\",\n      \"pmids\": [\"34610301\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Specific AP-1 elements driving transition not enumerated\", \"Single lab\"]\n    },\n    {\n      \"year\": 2023,\n      \"claim\": \"Defined c-Fos as a metabolic regulator in chondrocytes balancing pyruvate flux, with loss exacerbating osteoarthritis and rescuable by Pdk inhibition.\",\n      \"evidence\": \"Cartilage-specific c-fos knockout, DMM OA model, in situ enzyme assays, RNA-seq, and DCA rescue\",\n      \"pmids\": [\"37344157\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Direct transcriptional targets controlling Pdh/Ldh/HIF-1α axis not pinpointed\", \"Whether the effect is AP-1-dependent not resolved\"]\n    },\n    {\n      \"year\": 2023,\n      \"claim\": \"Identified PRMT1-mediated arginine-287 methylation as a stabilizing modification protecting c-Fos from autophagic degradation and enhancing AP-1 activity.\",\n      \"evidence\": \"Co-IP, mass spectrometry of methylation sites, PRMT1 knockdown, autophagy inhibition, and AP-1 reporters\",\n      \"pmids\": [\"37564212\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Full R287 mutagenesis validation not described\", \"Autophagy receptor recognizing unmethylated c-Fos unknown\"]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"How nuclear AP-1 transcription-factor c-Fos and the cytoplasmic ER-bound lipid-activating c-Fos pools are partitioned, coordinated, and integrated within a single cell remains unresolved.\",\n      \"evidence\": \"\",\n      \"pmids\": [],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"No structural model linking the two activities\", \"Signals dictating nuclear vs ER fate not fully defined\", \"Stoichiometry between pools unknown\"]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0140110\", \"supporting_discovery_ids\": [3, 5, 7, 23, 26, 30]},\n      {\"term_id\": \"GO:0003677\", \"supporting_discovery_ids\": [5, 23]},\n      {\"term_id\": \"GO:0098772\", \"supporting_discovery_ids\": [9, 11, 12]},\n      {\"term_id\": \"GO:0060090\", \"supporting_discovery_ids\": [22, 21]}\n    ],\n    \"localization\": [\n      {\"term_id\": \"GO:0005634\", \"supporting_discovery_ids\": [3, 5, 21]},\n      {\"term_id\": \"GO:0005783\", \"supporting_discovery_ids\": [9, 10, 11, 12]}\n    ],\n    \"pathway\": [\n      {\"term_id\": \"R-HSA-74160\", \"supporting_discovery_ids\": [3, 5, 29, 30, 32]},\n      {\"term_id\": \"R-HSA-1266738\", \"supporting_discovery_ids\": [0, 25, 26, 17]},\n      {\"term_id\": \"R-HSA-1430728\", \"supporting_discovery_ids\": [9, 11, 12, 27]},\n      {\"term_id\": \"R-HSA-162582\", \"supporting_discovery_ids\": [7, 15, 20, 24]}\n    ],\n    \"complexes\": [\"AP-1\"],\n    \"partners\": [\"JUN\", \"JUNB\", \"JUND\", \"PRMT1\", \"CDS1\", \"PI4K2A\", \"UGCG\", \"STAT3\"],\n    \"other_free_text\": []\n  }\n}","audit_flag":null,"evaluation":{"pairwise":"win","faith_supported":5,"faith_total":5,"faith_pct":100.0}}